MTOR - mechanistic target of rapamycin kinase Gene

Also Known as SKS; FRAP; FRAP1; FRAP2; RAFT1; RAPT1

Species: Homo sapiens

Gene Type: protein coding

Gene ID: 2475

About MTOR

Cytogenetic location: 1p36.22 Genomic coordinates (GRCh38): 1:11,106,535-11,262,551 (from NCBI)

This gene has 16 transcripts (splice variants), 217 orthologues, 5 paralogues and is associated with 155 phenotypes. Broad expression in testis (RPKM 23.6), brain (RPKM 8.1) and 25 other tissues.

Summary

The protein encoded by this gene belongs to a family of phosphatidylinositol kinase-related kinases. These kinases mediate cellular responses to stresses such as DNA damage and nutrient deprivation. This kinase is a component of two distinct complexes, mTORC1, which controls protein synthesis, cell growth and proliferation, and mTORC2, which is a regulator of the actin Cytoskeleton, and promotes cell survival and cell cycle progression. This protein acts as the target for the cell-cycle arrest and immunosuppressive effects of the FKBP12-rapamycin complex. Inhibitors of mTOR are used in organ transplants as immunosuppressants, and are being evaluated for their therapeutic potential in SARS-CoV-2 infections. Mutations in this gene are associated with Smith-Kingsmore syndrome and somatic focal cortical dysplasia type II. The ANGPTL7 gene is located in an intron of this gene. [provided by RefSeq, Aug 2020]

MTOR Products (8)

mRNA	Protein	Name
NM_001386500.1	NP_001373429.1	serine/threonine-protein kinase mTOR isoform 1
XM_011541166.3	XP_011539468.1	serine/threonine-protein kinase mTOR isoform X4
XM_047416724.1	XP_047272680.1	serine/threonine-protein kinase mTOR isoform X3
NM_001386501.1	NP_001373430.1	serine/threonine-protein kinase mTOR isoform 2
XR_007058581.1
NM_004958.4	NP_004949.1	serine/threonine-protein kinase mTOR isoform 1
XM_017000900.1	XP_016856389.1	serine/threonine-protein kinase mTOR isoform X2
XM_047416721.1	XP_047272677.1	serine/threonine-protein kinase mTOR isoform X1

Gene Ontology

Molecular Function
Biological Process
Cellular Component

Molecular Function GO Annotation	Evidence	References	Source
enables RNA polymerase III type 1 promoter sequence-specific DNA binding	IDA IDA: Inferred from direct assay	20233713	GOA
enables RNA polymerase III type 2 promoter sequence-specific DNA binding	IDA IDA: Inferred from direct assay	20233713	GOA
enables RNA polymerase III type 3 promoter sequence-specific DNA binding	IDA IDA: Inferred from direct assay	20233713	GOA
enables TFIIIC-class transcription factor complex binding	IDA IDA: Inferred from direct assay	20543138	GOA
enables identical protein binding	IPI IPI: Inferred from physical interaction	11438723	GOA
enables kinase activity	IDA IDA: Inferred from direct assay	15467718	GOA
enables phosphoprotein binding	IPI IPI: Inferred from physical interaction	11853878	GOA
enables protein binding	IPI IPI: Inferred from physical interaction	10089303	GOA
enables protein kinase activity	IDA IDA: Inferred from direct assay	12150926	GOA
enables protein serine/threonine kinase activity	EXP EXP: Inferred from Experiment	22768106	GOA
enables protein serine/threonine kinase activity	IDA IDA: Inferred from direct assay	12087098	GOA

Biological Process GO Annotation	Evidence	References	Source
involved in TOR signaling	IMP IMP: Inferred from mutant phenotype	15467718	GOA
involved in TORC1 signaling	IDA IDA: Inferred from direct assay	12087098	GOA
involved in TORC1 signaling	IMP IMP: Inferred from mutant phenotype	12718876	GOA
involved in cellular response to L-leucine	IDA IDA: Inferred from direct assay	22424946	GOA
involved in cellular response to amino acid starvation	IDA IDA: Inferred from direct assay	22343943	GOA
involved in cellular response to amino acid stimulus	IDA IDA: Inferred from direct assay	22424946	GOA
involved in cellular response to insulin stimulus	IDA IDA: Inferred from direct assay	18372248	GOA
involved in cellular response to leucine starvation	IDA IDA: Inferred from direct assay	22424946	GOA
involved in cellular response to methionine	IDA IDA: Inferred from direct assay	38006878	GOA
involved in cellular response to nutrient	IDA IDA: Inferred from direct assay	22017875	GOA
involved in cellular response to nutrient levels	IDA IDA: Inferred from direct assay	29750193	GOA
involved in cellular response to starvation	IDA IDA: Inferred from direct assay	22343943	GOA
involved in lysosome organization	IDA IDA: Inferred from direct assay	22692423	GOA
involved in negative regulation of autophagy	IDA IDA: Inferred from direct assay	22576015	GOA
involved in negative regulation of autophagy	IMP IMP: Inferred from mutant phenotype	22424946	GOA
involved in negative regulation of lysosome organization	IDA IDA: Inferred from direct assay	24448649	GOA
acts upstream of or within negative regulation of macroautophagy	IDA IDA: Inferred from direct assay	25327288	GOA
involved in negative regulation of protein localization to nucleus	IDA IDA: Inferred from direct assay	22692423	GOA
involved in nucleus localization	IDA IDA: Inferred from direct assay	22343943	GOA
involved in peptidyl-serine phosphorylation	IDA IDA: Inferred from direct assay	22343943	GOA
involved in peptidyl-serine phosphorylation	IMP IMP: Inferred from mutant phenotype	20537536	GOA
acts upstream of or within phosphorylation	IDA IDA: Inferred from direct assay	25327288	GOA
involved in phosphorylation	IDA IDA: Inferred from direct assay	11853878	GOA
involved in positive regulation of epithelial to mesenchymal transition	IMP IMP: Inferred from mutant phenotype	27919618	GOA
involved in positive regulation of gene expression	IMP IMP: Inferred from mutant phenotype	17028174	GOA
involved in positive regulation of keratinocyte migration	IMP IMP: Inferred from mutant phenotype	27919618	GOA
involved in positive regulation of lipid biosynthetic process	IMP IMP: Inferred from mutant phenotype	18762023	GOA
involved in positive regulation of transcription by RNA polymerase III	IMP IMP: Inferred from mutant phenotype	20233713	GOA
involved in positive regulation of transcription of nucleolar large rRNA by RNA polymerase I	IMP IMP: Inferred from mutant phenotype	24036451	GOA
involved in positive regulation of translation	IDA IDA: Inferred from direct assay	18762023	GOA
involved in positive regulation of translational initiation	IDA IDA: Inferred from direct assay	22578813	GOA
involved in positive regulation of wound healing, spreading of epidermal cells	IMP IMP: Inferred from mutant phenotype	27919618	GOA
acts upstream of or within protein autophosphorylation	IDA IDA: Inferred from direct assay	15467718	GOA
acts upstream of protein destabilization	IDA IDA: Inferred from direct assay	36608670	GOA
acts upstream of or within protein phosphorylation	IDA IDA: Inferred from direct assay	15467718	GOA
involved in protein phosphorylation	IDA IDA: Inferred from direct assay	18925875	GOA
involved in protein phosphorylation	IMP IMP: Inferred from mutant phenotype	17028174	GOA
involved in regulation of actin cytoskeleton organization	IMP IMP: Inferred from mutant phenotype	15467718	GOA
involved in regulation of autophagosome assembly	IDA IDA: Inferred from direct assay	23524951	GOA
involved in regulation of cell growth	IDA IDA: Inferred from direct assay	18762023	GOA
involved in regulation of cell size	IMP IMP: Inferred from mutant phenotype	22424946	GOA
involved in response to amino acid	IDA IDA: Inferred from direct assay	18497260	GOA
involved in response to nutrient	IMP IMP: Inferred from mutant phenotype	17028174	GOA
involved in response to nutrient levels	IDA IDA: Inferred from direct assay	29750193	GOA

Cellular Component GO Annotation	Evidence	References	Source
part of TORC1 complex	IDA IDA: Inferred from direct assay	12150926	GOA
part of TORC1 complex	IMP IMP: Inferred from mutant phenotype	20537536	GOA
part of TORC1 complex	IPI IPI: Inferred from physical interaction	26678875	GOA
part of TORC2 complex	IDA IDA: Inferred from direct assay	15467718	GOA
part of TORC2 complex	IPI IPI: Inferred from physical interaction	17461779	GOA
located in cytoplasm	IDA IDA: Inferred from direct assay	11853878	GOA
is active in cytosol	IDA IDA: Inferred from direct assay	30956113	GOA
located in endomembrane system	IDA IDA: Inferred from direct assay	18497260	GOA
is active in lysosomal membrane	IDA IDA: Inferred from direct assay	31112131	GOA
located in lysosomal membrane	IDA IDA: Inferred from direct assay	30956113	GOA
located in lysosome	IDA IDA: Inferred from direct assay	20381137	GOA
located in lysosome	IMP IMP: Inferred from mutant phenotype	22424946	GOA
located in membrane	IDA IDA: Inferred from direct assay	11853878	GOA
located in nuclear envelope	IDA IDA: Inferred from direct assay	25294810	GOA
located in phagocytic vesicle	IDA IDA: Inferred from direct assay	27623384	GOA

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

MTOR Protein Structure

DUF3385

FAT

FRB_dom

PI3_PI4_kinase

FATC

0
400
800
1200
1600
2000
2400
2549 a.a.

Protein Preferred Names	Protein Names
serine/threonine-protein kinase mTOR	FK506 binding protein 12-rapamycin associated protein 2 FK506-binding protein 12-rapamycin complex-associated protein 1 FKBP-rapamycin associated protein FKBP12-rapamycin complex-associated protein 1 mammalian target of rapamycin mechanistic target of rapamycin (serine/threonine kinase) rapamycin and FKBP12 target 1 rapamycin associated protein FRAP2 rapamycin target protein 1

MTOR Protein-protein interaction Information

Type	Protein Name	Protein ID	Interactor	Interactor Species	Interactor ID	Detection Method	References
Intra	MTOR	P42345	FKBP1A	Homo sapiens	P62942	X-Ray Diffraction	10089303
Intra	MTOR	P42345	FKBP1A	Homo sapiens	P62942	BRET	29997244
Intra	MTOR	P42345	FKBP1A	Homo sapiens	P62942	Lumier	29997244
Intra	MTOR	P42345	PREX1	Homo sapiens	Q8TCU6	Anti Tag CoIP	17565979
Intra	MTOR	P42345	PREX1	Homo sapiens	Q8TCU6	Y2H	17565979
Intra	MTOR	P42345	PREX1	Homo sapiens	Q8TCU6	Anti Bait CoIP	17565979
Intra	MTOR	P42345	PREX1	Homo sapiens	Q8TCU6	Pull Down	17565979
Intra	MTOR	P42345	RHEB	Homo sapiens	Q15382	Anti Tag CoIP	16098514
Intra	MTOR	P42345	RICTOR	Homo sapiens	Q6R327	Density Sedimentation	21376236
Intra	MTOR	P42345	RICTOR	Homo sapiens	Q6R327	Anti Bait CoIP	19875983
Intra	MTOR	P42345	RICTOR	Homo sapiens	Q6R327	Anti Bait CoIP	27043084
Intra	MTOR	P42345	RICTOR	Homo sapiens	Q6R327	Anti Bait CoIP	19446321
Intra	MTOR	P42345	RICTOR	Homo sapiens	Q6R327	Anti Bait CoIP	18566587
Intra	MTOR	P42345	RICTOR	Homo sapiens	Q6R327	Anti Bait CoIP	17461779
Intra	MTOR	P42345	RICTOR	Homo sapiens	Q6R327	Anti Bait CoIP	24375676
Intra	MTOR	P42345	RICTOR	Homo sapiens	Q6R327	Anti Tag CoIP	35271311
Intra	MTOR	P42345	RICTOR	Homo sapiens	Q6R327	Anti Bait CoIP	23953116
Intra	MTOR	P42345	RICTOR	Homo sapiens	Q6R327	Density Sedimentation	21045808
Intra	MTOR	P42345	MLST8	Homo sapiens	Q9BVC4	Anti Bait CoIP	17461779
Intra	MTOR	P42345	MLST8	Homo sapiens	Q9BVC4	Anti Bait CoIP	26348909
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	Anti Tag CoIP	35271311
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	Anti Bait CoIP	19875983
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	Light Scattering	26678875
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	Anti Bait CoIP	18955708
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	3D-EM	26678875
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	Solid Phase Assay	21614075
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	Anti Bait CoIP	12150926
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	Anti Bait CoIP	19446321
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	Anti Bait CoIP	26348909
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	Anti Bait CoIP	25446900
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	Anti Tag CoIP	26348909
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	Anti Bait CoIP	22424946
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	Anti Bait CoIP	17461779
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	X-Ray Diffraction	26678875
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	PLA	23953116
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	Anti Bait CoIP	23953116
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	GMS	26678875
Intra	MTOR	P42345	RPTOR	Homo sapiens	Q8N122	Density Sedimentation	21045808
Intra	MTOR	P42345	MLST8	Homo sapiens	Q9BVC4-1	Light Scattering	26678875
Intra	MTOR	P42345	MLST8	Homo sapiens	Q9BVC4-1	X-Ray Diffraction	26678875
Intra	MTOR	P42345	MLST8	Homo sapiens	Q9BVC4-1	GMS	23636326
Intra	MTOR	P42345	MLST8	Homo sapiens	Q9BVC4-1	GMS	26678875
Intra	MTOR	P42345	MLST8	Homo sapiens	Q9BVC4-1	3D-EM	26678875
Intra	MTOR	P42345	MLST8	Homo sapiens	Q9BVC4-1	Ion Exchange Chrom	23636326
Intra	MTOR	P42345	MLST8	Homo sapiens	Q9BVC4-1	X-Ray Diffraction	23636326
Intra	MTOR	P42345	CLEC4G	Homo sapiens	Q6UXB4	Anti Tag CoIP	33106485
Intra	MTOR	P42345	CLEC4G	Homo sapiens	Q6UXB4	Anti Bait CoIP	33106485
Intra	MTOR	P42345	DEPTOR	Homo sapiens	Q8TB45	Anti Bait CoIP	19446321
Intra	MTOR	P42345	BCL2L1	Homo sapiens	Q07817-1	Protein Kinase Assay	20080789
Intra	MTOR	P42345	AKT1	Homo sapiens	P31749	Anti Tag CoIP	24670654
Intra	MTOR	P42345	AKT1	Homo sapiens	P31749	Protein Kinase Assay	24670654
Intra	MTOR	P42345	AKT1	Homo sapiens	P31749	PLA	25241761
Intra	MTOR	P42345	YWHAZ	Homo sapiens	P63104	Pull Down	15161933
Intra	MTOR	P42345	PLEKHM1	Homo sapiens	Q9Y4G2	Confocal	33452816
Intra	MTOR	P42345	PLEKHM1	Homo sapiens	Q9Y4G2	Anti Tag CoIP	33452816
Intra	MTOR	P42345	PLEKHM1	Homo sapiens	Q9Y4G2	Protein Kinase Assay	33452816
Intra	MTOR	P42345	TM9SF4	Homo sapiens	Q92544	PLA	29125601
Intra	MTOR	P42345	TM9SF4	Homo sapiens	Q92544	Confocal	29125601
Intra	MTOR	P42345	RAB1A	Homo sapiens	P62820	Anti Bait CoIP	25446900
Intra	MTOR	P42345	EIF4EBP1	Homo sapiens	Q13541	Protein Kinase Assay	12150926

Cross: Cross-species interaction Intra: Intraspecies interaction

MTOR Antibodies

Cat. No.	Product Name	Application	Reactivity
HY-P80231	mTOR Antibody (YA281)	WB, IHC-P, ICC/IF, IP, IF-Tissue	Human, Mouse, Rat
HY-P80469	Phospho-mTOR (Ser2448) Antibody (YA691)	WB, IHC-P	Human, Mouse, Rat
HY-P80759	mTOR Antibody	WB, IHC-P, ICC/IF, IP, FC	Human, Mouse, Rat
HY-P80837	Phospho-mTOR (Ser2448) Antibody (YA171)	WB, IHC-P	Human, Mouse
HY-P80837A	Phospho-mTOR (Ser2448) Antibody (YA171)(PBS only)	WB, IHC-P	Human, Mouse
HY-P80838	Phospho-mTOR (Ser2481) Antibody	WB	Human, Mouse, Rat
HY-P86383	Phospho-mTOR(Ser2448) Antibody (YA6075)	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
HY-P86389	mTOR Antibody (YA6081)	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat

Related Diseases

Diseases	Alias
Ocular Hypertension	Hypertension, Ocular Intraocular Pressure Increase Oh - [Ocular Hypertension] Oht - [Ocular Hypertension]
West Syndrome	Infantile Spasms Infantile Spasms Syndrome Infantile Spasm X-Linked Infantile Spasm Syndrome X-Linked Infantile Spasms Epileptic Encephalopathy, Early Infantile, 1 Is Tonic Spasms With Clustering, Arrest Of Psychomotor Development And Hypsarrhythmia On Eeg West'S Syndrome Spasms, Infantile Is -[Infantile Spasm] Salaam Spasm Salaam Tic
Skin Melanoma	Cutaneous Melanoma Malignant Ear Melanoma Malignant Lip Melanoma Malignant Lower Limb Melanoma Malignant Melanoma Of Ear And/Or External Auricular Canal Malignant Melanoma Of Skin Of Lower Limb Malignant Melanoma Of Skin Of Trunk Except Scrotum Malignant Melanoma Of Skin Of Upper Limb Malignant Neck Melanoma Malignant Scalp Melanoma Malignant Trunk Melanoma Malignant Upper Limb Melanoma Melanoma, Cutaneous Malignant Melanoma Malignant Melanoma Of Skin Melanoma Nos Malignant Mole, Meaning Melanoma Of Unspecified Site Melanoma Of Unspecified Site Cutaneous Malignant Melanoma Mm - [Malignant Melanoma]
Acute Promyelocytic Leukemia	Leukemia, Acute Promyelocytic Acute Myeloblastic Leukemia Type 3 Aml M3 APL Leukemia, Acute Promyelocytic, Somatic Aml With T(15 17)(Q22 Q12) (Pml/Raralpha) And Variants Apml Acute Myeloblastic Leukemia 3 Acute Myeloid Leukemia With T(15 17)(Q22 Q12) (Pml/Raralpha) And Variants Acute Myeloblastic Leukaemia Type 3 Acute Myeloid Leukaemia M3 Acute Myeloid Leukemia M3 Acute Promyelocytic Leukaemia M3 Anll Myeloid Leukemia, Acute, M3 Leukemia Promyelocytic Acute Leukemia, Promyelocytic, Acute Leukemia, Acute, Promyelocytic
Pancreatic Cancer	Pancreatic Carcinoma Familial Pancreatic Carcinoma Pancreatic Neoplasm Carcinoma Of Pancreas Pancreatic Carcinoma, Familial Malignant Neoplasm Of Pancreas Pancreatic Acinar Carcinoma Pancreatic Tumor Familial Pancreatic Cancer Neoplasm Of The Pancreas Pancreatic Carcinoma, Somatic Pancreatic Cancer, Somatic Ca Body Of Pancreas Ca Head Of Pancreas Ca Tail Of Pancreas Malignant Neoplasm Of Body Of Pancreas Malignant Neoplasm Of Head Of Pancreas Malignant Neoplasm Of Tail Of Pancreas Pancreas Neoplasm Exocrine Cancer Exocrine Pancreas Carcinoma Hereditary Pancreatic Cancer Hereditary Pancreatic Carcinoma PNCA Cancer Of The Pancreas Pancreatic Cancer, Susceptibility To Carcinoma Of Head Of Pancreas Pancreatic Neoplasms Pancreatic Tumors Cancer, Pancreatic Cancer Of Pancreas Mixed Islet Cell With Exocrine Carcinoma Of Unspecified Site
Angiomyolipoma	Angiomyolipoma Of Kidney
Leukemia, Acute Myeloid	Acute Myeloid Leukemia Leukemia, Acute Myelogenous Acute Myelogenous Leukemia AML Leukemia, Acute Myeloid, Susceptibility To Acute Myeloblastic Leukemia Leukemia, Acute Myeloid, Reduced Survival In, Somatic Acute Myeloid Leukaemia Leukemia, Myelocytic, Acute Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome Secondary Aml Acute Myelocytic Leukemia Leukemia, Myeloid, Acute Acute Myeloid Leukemia, Somatic Leukemia, Acute Myeloid, Somatic Myeloid Leukemia, Acute, M4/M4eo Subtype, Somatic Acute Myeloblastic Leukaemia Acute Myelogenous Leukaemia Aml - Acute Myeloid Leukemia Acute Myeloid Leukemia With Cebpa Somatic Mutations Aml With Cebpa Somatic Mutations Inherited Acute Myeloid Leukemia Familial Aml Inherited Aml Pure Familial Aml Pure Familial Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Therapy-Related Aml And Myelodysplastic Syndrome Acute Myeloid Leukemia, Secondary Acute Non-Lymphoblastic Leukemia Acute Non-Lymphocytic Leukemia Acute Biphenotypic Leukemia Acute Undifferentiated Leukemia Acute Myeloblastic Leukaemia With Multilineage Dysplasia Acute Myeloid Leukaemia With Multilineage Dysplasia Without Mention Of Remission Acute Myeloid Leukaemia With Myelodysplasia-Related Features
Lymphangioleiomyomatosis	Lymphangiomyomatosis LAM Lung Lymphangioleiomyomatosis Pulmonary Lymphangioleiomyomatosis Lymphangioleiomyomatosis, Somatic Lymphangio-Myomatosis
Autism Spectrum Disorder	Asd Autism Spectrum Disorders Autistic Continuum Pervasive Developmental Disorder Pervasive Development Disorder Autistic Behavior Autistic Disorder Autistic Autistic Disorder Of Childhood Onset Infantile Autism Childhood Autism Kanner Syndrome Pervasive Developmental Delay Nos Pervasive Developmental Disorder, Not Otherwise Specified
Corneal Dystrophy, Fleck	Fleck Corneal Dystrophy Fcd CFD Corneal Fleck Dystrophy Francois-Neetens Speckled Corneal Dystrophy Corneal Dystrophy, Francois-Neetens Speckled Or Flecked Corneal Dystrophy Francois-Neetens Speckled Or Flecked Dystrophy, Corneal, Fleck
Myopathy	Muscular Diseases Myopathies
Hydrocephalus	Hydrocephalus, Nonsyndromic, Autosomal Recessive Hydrocephalus, X-Linked Hydrocephalus Adverse Event Hydrocephaly Nos
Cebalid Syndrome	Mn1 C-Terminal Truncation Syndrome CEBALID Craniofacial Defects, Dysmorphic Ears, Structural Brain Abnormalities, Expressive Language Delay, And Impaired Intellectual Development Mctt Mctt Syndrome Mn1 C-Terminal Truncation Syndrome
Focal Cortical Dysplasia, Type Ii	Focal Cortical Dysplasia Of Taylor Cortical Dysplasia Of Taylor Cdt Fcdt Isolated Focal Cortical Dysplasia Type Ii FCORD2 Fcd2 Focal Cortical Dysplasia Type 2 Cortical Dysplasia Of Taylor, Dysplasia Only Focal Cortical Dysplasia, Type Ii, Somatic Focal Cortical Dysplasia Type Ii Isolated Focal Cortical Dysplasia Type Iib Fcd Type Iib Cortical Dysplasia, Taylor Type Fcd Type Ii Isolated Focal Cortical Dysplasia Type 2 Isolated Focal Cortical Dysplasia Type Iia Fcd Type Iia Isolated Focal Cortical Dysplasia Epilepsy Due To Fcd Focal Cortical Dysplasia 2 Cdtbc Cdtd Cortical Dysplasia Of Taylor With Balloon Cells Cortical Dysplasia Of Taylor Without Balloon Cells Fcd Iia Fcd Iib Fcord2a Fcord2b Focal Cortical Dysplasia, Type Iia Focal Cortical Dysplasia, Type Iib Focal Cortical Dysplasia Of Taylor Balloon Cell Type FCDBC Focal Cortical Dysplasia, Taylor Balloon Cell Type Dysplasia, Cortical, Focal Type Ii Focal Cortical Dysplasia Of Taylor, Type Iib
Cowden Syndrome	Cowden Disease Multiple Hamartoma Syndrome Cowden'S Disease Lhermitte-Duclos Disease Cd Cs Mham Dysplastic Gangliocytoma Of Cerebellum Cowden'S Syndrome Hamartoma Syndrome, Multiple
Sarcoma	Connective And Soft Tissue Neoplasm Tumor Of Soft Tissue And Skeleton Sarcomas Sarcoma - Category
Benign Epilepsy With Centrotemporal Spikes	Benign Rolandic Epilepsy Rolandic Epilepsy Epilepsy, Rolandic Bcects Benign Childhood Epilepsy With Centrotemporal Spike Sylvan Seizures Becrs Bects Bre Benign Epilepsy Of Childhood With Centrotemporal Spikes Benign Familial Epilepsy Of Childhood With Rolandic Spikes Centrotemporal Epilepsy
Central Nervous System Benign Neoplasm	Benign Neoplasm Of The Central Nervous System
Lymphocele	Lymph Cyst Lymphocele Adverse Event
Gliosarcoma	Glioblastoma With Sarcomatous Component Sarcomatous Glioblastoma
Gastrointestinal Neuroendocrine Tumor	Gastrointestinal Neuroendocrine Tumour Malignant Gastrointestinal Neuroendocrine Tumor Malignant Gastrointestinal Neuroendocrine Tumour Digestive System Neuroendocrine Neoplasm Digestive System Neuroendocrine Tumor
Polycystic Liver Disease	Autosomal Dominant Polycystic Liver Disease Isolated Polycystic Liver Disease Pcld Congenital Cystic Liver Disease Congenital Hepatic Cyst Fibrocystic Liver Disease Isolated Autosomal Dominant Polycystic Liver Disease Adpcld Liver Disease, Polycystic Multiple Cysts Of Liver Pld - [Polycystic Liver Disease] Polycystic Liver Disorder Polycystic Liver Congenital Polycystic Disease Of Liver Congenital Polycystic Liver Disease
Colorectal Cancer	Colon Cancer Colorectal Carcinoma Colon Carcinoma Colorectal Cancer, Susceptibility To Carcinoma Of Colon CRC Colorectal Cancer With Chromosomal Instability, Somatic Colon Cancer, Somatic Colon Cancer, Susceptibility To Colonic Neoplasms Colorectal Neoplasms Colorectal Cancer, Somatic Colon Cancer, Advanced, Somatic Colonic Carcinoma Colorectal Carcinomas Colon Cancers Colorectal Cancers Cancer, Colorectal, Somatic Cancer, Colon Cancer, Colorectal, Susceptibility To Colorectal Neoplasm Colonic Neoplasm Malignant Tumor Of Colon
Bladder Urothelial Carcinoma	Bladder Transitional Cell Carcinoma Transitional Cell Carcinoma Of Bladder Transitional Cell Carcinoma Of The Bladder Urinary Bladder Urothelial Carcinoma Urothelial Bladder Carcinoma Carcinoma Transitional Cell Bladder Tcc - [Transitional Cell Carcinoma] Of Bladder
Alexander Disease	Alexander'S Disease ALXDRD Alexanders Leukodystrophy Axd Megalencephaly In Infancy Accompanied By Progressive Spasticity And Dementia Alx Demyelinogenic Leukodystrophy Dysmyelinogenic Leukodystrophy Fibrinoid Degeneration Of Astrocytes Leukodystrophy With Rosenthal Fibers Alexander Disease Type Ii Axd Type Ii Alexander Disease Type I Axd Type I Alexanders Disease Alexander'S Leukodystrophy
Myeloma, Multiple	Multiple Myeloma Kahler Disease Myelomatosis Plasma Cell Myeloma Medullary Plasmacytoma Multiple Myeloma, Resistance To Myeloma Plasma Cell Dyscrasia Multiple Myeloma, Susceptibility To Myeloma - Multiple Kahler'S Disease Kahler-Bozzolo Disease Plasma Cell Myelomas MM Plasma Cell Neoplasm Primary Systemic Amyloidosis Primary Amyloidosis Immunoglobulin Deposition Disease Plasmacytic Myeloma Multiple Myelomata Multiple Myeloma Nos Multiple Myeloma Without Mention Of Remission Monostotic Plasma Cell Myeloma Mm - [Multiple Myeloma]
Cystic Kidney Disease	Renal Cyst Simple Renal Cyst Kidney Cysts Kidney Diseases, Cystic Renal Cysts Kidney Cyst Cystic Kidney Congenital Cystic Kidney Disease Cystic Kidney Diseases Bosniak 1 Cyst
Autoimmune Lymphoproliferative Syndrome	ALPS Canale-Smith Syndrome Autoimmune Lymphoproliferative Syndrome, Type Ia Autoimmune Lymphoproliferative Syndrome, Type Ib Autoimmune Lymphoproliferative Syndrome Type 1, Autosomal Dominant Css Autoimmune Lymphoproliferative Syndrome, Type 1b Autoimmune Lymphoproliferative Syndrome, Type 1a Autoimmune Lymphoproliferative Syndrome, Type I, Autosomal Dominant Fas Deficiency Autoimmune Lymphoproliferative Syndrome 1a ALPS1A Autoimmune Lymphoproliferative Syndrome Type Ia Autoimmune Lymphoproliferative Syndrome 1b ALPS1B Autoimmune Lymphoproliferative Syndrome Type Ib
Gastric Adenocarcinoma	Adenocarcinoma Of Stomach Stomach Adenocarcinoma Adenocarcinoma Gastric Intestinal Type Adenocarcinoma Of Unspecified Site Diffuse Type Adenocarcinoma Of Unspecified Site
Estrogen-Receptor Positive Breast Cancer
Exanthem	Exanthema Rash Rashes
Glioblastoma	Glioblastoma Multiforme Gbm Adult Glioblastoma Multiforme Grade Iv Adult Astrocytic Tumor Primary Glioblastoma Multiforme Spongioblastoma Multiforme Adult Glioblastoma Primary Glioblastoma
Lung Squamous Cell Carcinoma	Squamous Cell Carcinoma Of Lung Squamous Cell Lung Carcinoma Epidermoid Cell Carcinoma Of The Lung Squamous Cell Lung Cancer
Thymoma	Primary Thymic Epithelial Neoplasm Primary Thymic Epithelial Tumor Thymus Neoplasms
Plasmacytoma	Solitary Plasmacytoma Solitary Myeloma Myeloma - Solitary Myeloma, Solitary Plasmacytoma - Category Solitary Osseous Plasmacytoma Solitary Plasmacytoma Without Mention Of Remission Localised Malignant Plasma Cell Tumour Nos Plasmacytoma Nos
Spinal Cord Disease	Spinal Cord Diseases Myelopathy Bone Marrow Diseases
Tuberous Sclerosis	Tuberous Sclerosis Syndrome Bourneville'S Disease Epiloia Cerebral Sclerosis Tuberose Sclerosis Tuberous Sclerosis 1 Bourneville Disease Bourneville Phakomatosis Pringle'S Disease
Pyriform Sinus Cancer	Malignant Neoplasm Of Pyriform Fossa Malignant Neoplasm Of The Pyriform Fossa Malignant Tumor Of Pyriform Fossa
Eye Disease	Eye Diseases Abnormality Of The Eye Toxoplasma Oculopathy
Rhabdomyosarcoma
Aging
Parkinson Disease, Late-Onset	Parkinson Disease Parkinson'S Disease PD PARK Parkinson Disease, Susceptibility To Late Onset Parkinson'S Disease Late Onset Parkinson Disease Paralysis Agitans Primary Parkinsonism Idiopathic Parkinson Disease Parkinson'S Parkinson Disease, Late-Onset, Susceptibility To Parkinson Disease, Age Of Onset, Modifier Lewy Body Parkinson Disease Idiopathic Parkinson'S Disease Pd - [Parkinson Disease] Parkinson Disease Nos Parkinson, Nos Primary Parkinson Disease
Fragile X Syndrome	FXS Martin-Bell Syndrome Fraxa Syndrome Marker X Syndrome X-Linked Mental Retardation And Macroorchidism Fragile X Mental Retardation Syndrome Fra Syndrome Mental Retardation, X-Linked, Associated With Marxq28 Frax Syndrome Symptomatic Form Of Fragile X Syndrome In Female Carriers Fragile-X Syndrome Fraxe Syndrome
Congenital Lipomatous Overgrowth, Vascular Malformations, And Epidermal Nevi	Cloves Syndrome Clove Syndrome Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, And Skeletal/Spinal Abnormalities Clove Syndrome, Somatic Congenital Lipomatous Overgrowth - Vascular Malformation - Epidermal Nevi Congenital Lipomatous Overgrowth-Vascular Malformation-Epidermal Nevi-Skeletal Anomaly Syndrome Congenital Lipomatous Overgrowth-Vascular Malformation-Epidermal Nevi-Spinal Anomaly Syndrome CLOVE Congenital Lipomatous Overgrowth Vascular Malformations Epidermal Nevi And Skeletal/Spinal Abnormalities Congenital Arteriovenous Malformation Arteriovenous Hemangioma Nevus Melanocytic Nevus Benign Melanocytic Nevus
Thymus Cancer	Thymic Tumor Thymus Neoplasm Thymus Neoplasms Malignant Neoplasm Of Thymus Neoplasm Of Thymus Thymic Neoplasm Thymic Neoplasms Thymoma, Familial Thymic Carcinoma Thymoma, Type C Cancer Of Thymus Malignant Tumour Of Thymus Primary Malignant Neoplasm Of Thymus Thymic Glandular Cancer Thymus Gland Cancer
Gastrointestinal Stromal Tumor	GIST Gastrointestinal Stromal Tumors Gastrointestinal Stromal Sarcoma Gastrointestinal Stromal Tumor, Familial Gant Gastrointestinal Stromal Tumour Stromal Tumor Of Gastrointestinal Tract Stromal Tumour Of Gastrointestinal Tract Gastrointestinal Stromal Neoplasm Paraganglioma And Gastric Stromal Sarcoma Plexosarcoma
Hemangioma	Hemangiomas
Skin Disease	Skin Diseases Abnormality Of The Skin Skin Diseases, Genetic Genodermatosis Skin And Subcutaneous Tissue Disease Dermatologic Disorders
Exudative Vitreoretinopathy 4	EVR4 Vitreoretinopathy, Exudative 4 Vitreoretinopathy, Exudative, Type 4
Generalized Lymphatic Anomaly	Doid:0081031
Pulmonary Hypertension	Primary Pulmonary Hypertension Hypertension Pulmonary Hypertension, Pulmonary Idiopathic Pulmonary Hypertension Idiopathic Pulmonary Arterial Hypertension Pulmonary Htn - [Hypertension]
Epilepsy	Epilepsy Syndrome Epileptic Syndrome Epilepsies Symptomatic Epilepsies Post Traumatic Epilepsy Traumatic Epilepsy Traumatic Epileptic Epilepsy Due To Hippocampal Sclerosis Epilepsy With Ammon'S Horn Sclerosis Epilepsy Due To Cortical Dysplasia Epilepsy Due To Neuronal Migration Disorders
Neurodegeneration With Brain Iron Accumulation	Nbia Neurodegeneration With Brain Iron Accumulation Disorders Neurodegeneration, With Brain Iron Accumulation
Hypertension, Essential	Essential Hypertension Hypertension High Blood Pressure Hypertension, Essential, Susceptibility To Hypertensive Disease Primary Hypertension EHT Hypertension, Salt-Sensitive Essential, Susceptibility To Hyperpiesia Idiopathic Hypertension Hypertensive Disorder Hypertension, Essential, Susceptibility To, 3 Hypertension, Essential 3 Hypertension, Essential, Salt-Sensitive Hypertension, Essential, Susceptibility To, 6 Hypertension, Essential 6 Hypertension, Salt-Sensitive Essential Hypertension, Susceptibility To Hypertension, Essential, Susceptibility To, 4 Hypertension, Essential 4 Hypertension, Essential, Susceptibility To, 2 Hypertension, Essential 2 Hypertension, Essential, Susceptibility To, 1 Hypertension, Essential 1 Hypertension, Essential, Susceptibility To, 5 Hypertension, Essential 5 Htn Vascular Hypertensive Disorder Systemic Primary Arterial Hypertension Hbp - [High Blood Pressure] Systemic Arterial Hypertensive Disorder Elevated Blood Pressure Arterial Hypertension Nos Hypertension Nos Benign Hypertension Systemic Arterial Hypertension Systemic Hypertension Artery Htn Benign Htn Vascular Htn Vascular Hypertension Cholesterol Hypertension Cholesterol Htn Idiopathic Htn Malignant Hypertension Malignant Htn Raised Blood Pressure Cardiovascular Hypertension Primary Htn - [Hypertension] High Arterial Tension High Blood Pressure Disorder Ht - [Hypertension] Htn - [Hypertension] Hypertensive Vascular Disease Hypertensive Vascular Degeneration
Muscular Atrophy	Muscle Wasting Amyotrophia Wasting - Muscle Skeletal Muscle Atrophy
Squamous Cell Carcinoma	Epidermoid Carcinoma Squamous Cell Cancer Carcinoma, Squamous Cell Malignant Squamous Cell Tumor Squamous Carcinoma Squamous Cell Epithelioma Squamous Cell Skin Cancer Carcinoma Squamous Cell Neoplasms, Squamous Cell Squamous Cell Carcinoma - Category Malignant Squamous Cell Neoplasm Squamous Cell Carcinoma Of Skin
Malignant Pleural Mesothelioma	Malignant Mesothelioma Of Pleura Pleural Malignant Mesothelioma
Rett Syndrome	Atypical Rett Syndrome RTT Rts Autism, Dementia, Ataxia, And Loss Of Purposeful Hand Use Rett Syndrome, Atypical Rett Syndrome, Preserved Speech Variant Rett'S Disorder Rett Syndrome Variant Rett Disorder Cerebroatrophic Hyperammonemia Rett Like Syndrome Autism-Dementia-Ataxia-Loss Of Purposeful Hand Use Syndrome Rett'S Syndrome Atypical Rtt Autism-Dementia-Ataxia-Loss Of Purposeful Hand Use Rett Syndrome Preserved Speech Variant Rett Syndrome Zappella Variant Rett Syndrome, Zappella Variant
Subependymal Glioma	Mixed Subependymoma-Ependymoma Subependymal Astrocytoma Who Grade I Ependymal Tumor Glioma, Subependymal
Autism	Autistic Disorder Autism Susceptibility 1 Childhood Autism Autistic Disorder Of Childhood Onset Infantile Autism Kanner'S Syndrome Autistic
B-Cell Lymphoma	Lymphoma, B-Cell B-Cell Lymphomas B-Cell Lymphocytic Neoplasm Lymphoma B-Cell B-Cell Lymphoma Nos
Pervasive Developmental Disorder	Pervasive Development Disorder Pervasive Developmental Disorders Pervasive Child Development Disorders Autistic Behavior Autism Spectrum Disorders
Nervous System Disease	Abnormality Of The Nervous System Nervous System Diseases Nervous System Disorder
Chromophobe Renal Cell Carcinoma	Chromophobe Adenocarcinoma Chromophobe Carcinoma Of Kidney Kidney Chromophobe Renal Cell Carcinoma, Chromophobe Cell Crcc Chrcc Chromophobe Renal Cell Adenocarcinoma Chromophobe Renal Carcinoma Chromophobe Carcinoma
Optic Nerve Neoplasm	Optic Nerve Neoplasms Neoplasm Of Optic Nerve Tumor Of Second Cranial Nerve Tumour Of Optic Nerve
Kidney Angiomyolipoma	Angiomyolipoma Of Kidney Renal Angiomyolipoma
Contractures, Pterygia, And Spondylocarpotarsal Fusion Syndrome 1a	Multiple Pterygium Syndrome, Autosomal Dominant CPSFS1A Contractures, Pterygia, And Spondylocarpostarsal Fusion Syndrome 1a Autosomal Dominant Disease Contractures, Pterygia, And Variable Skeletal Fusions Syndrome 1a Cpskf1a Pterygium Syndrome, Multiple Autosomal Dominant Arthrogryposis, Distal, Type 8, Formerly Da8, Formerly Autosomal Dominant Multiple Pterygium Syndrome Distal Arthrogryposis Type 8 Arthrogryposis, Distal, Type 8 Da8 Pterygium Syndrome, Multiple, Autosomal Dominant Autosomal Dominant Disorder
Rasopathy	Ras/Mitogen-Activated Protein Kinase Syndrome
Paronychia	Paronychia Inflammation Onychomycosis Fungal Nail Infection Infected Nailfold Onychia And Paronychia Of Finger Onychia And Paronychia Of Toe Fungal Infection Of The Nails
Interstitial Lung Disease 2	Idiopathic Pulmonary Fibrosis Ipf Fibrocystic Pulmonary Dysplasia Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Idiopathic, Susceptibility To ILD2 Idiopathic Pulmonary Fibrosis, Familial Fibrosing Alveolitis, Cryptogenic Uip Cryptogenic Fibrosing Alveolitis Fibrosing Alveolitis Interstitial Pneumonitis, Usual Familial Idiopathic Pulmonary Fibrosis Idiopathic Fibrosing Alveolitis, Chronic Form Usual Interstitial Pneumonia Fibrosing Alveolitis Cryptogenic Hamman-Rich Disease Idiopathic Pulmonary Fibrosis Familial Interstitial Pneumonitis Usual Fibrosis Idiopathic Pulmonary Fibrosis, Pulmonary, Idiopathic Hamman-Rich Syndrome Chronic Idiopathic Pulmonary Fibrosis Acute Interstitial Pneumonia Interstitial Pulmonary Fibrosis Ipf - [Idiopathic Pulmonary Fibrosis] Idiopathic Lung Fibrosis Fibrosing Lung Disease Pulmonary Fibrosis Nos Fibrosing Pneumonitis
Low Grade Glioma	Benign Glioma
Medulloblastoma	MDB Cpnet Localized Primitive Neuroectodermal Tumor Classic Medulloblastoma Desmoplastic/Nodular Medulloblastoma Medulloblastoma With Extensive Nodularity Desmoplastic Medulloblastoma Medulloblastoma, Somatic Medulloblastoma, Desmoplastic Brain Medulloblastoma Cns Pnet Infratentorial Primitive Neuroectodermal Tumor Mben Medulloblastoma Desmoplastic Neuroectodermal Tumors, Primitive Medulloblastomas Medulloblastoma, With Extensive Nodularity Medulloblastoma Of Unspecified Site Medullomyoblastoma Of Unspecified Site
Laryngomalacia	Congenital Laryngomalacia Congenital Laryngeal Stridor Laryngomalacia Congenital Floppy Epiglottis
Acne	Acne Vulgaris Acne Varioliformis Frontalis Acne
Diabetes Mellitus	Diabetes
Umbilical Hernia	Hernia, Umbilical
Renal Cell Carcinoma, Nonpapillary	Renal Cell Carcinoma RCC Nonpapillary Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma Hypernephroma Adenocarcinoma Of Kidney Renal Carcinoma, Chromophobe, Somatic Clear Cell Carcinoma Of Kidney Clear-Cell Metastatic Renal Cell Carcinoma Clear Cell Renal Carcinoma Renal Cell Carcinoma, Somatic Conventional Renal Cell Carcinoma Conventional Renal Cell Carcinoma Renal Clear Cell Carcinoma Ccrcc Hereditary Clear Cell Renal Cell Carcinoma Carcinoma, Renal Cell Renal Cell Carcinoma, Clear Cell, Somatic Renal Cell Carcinoma, Clear Cell Clear Cell Kidney Carcinoma Clear Cell Rcc Cystic-Multilocular Variant Clear Cell Renal Cell Adenocarcinoma Hereditary Clear Cell Renal Cell Adenocarcinoma Common Renal Cell Carcinoma Crcc Renal Cell Carcinoma Non-Papillary Carcinoma Renal Cell Renal Cell Cancer Carcinoma, Renal Cell, Nonpapillary
Cervical Cancer	Cervical Cancer, Somatic Neoplasm Of Uterine Cervix Cervix Cancer Uterine Cervical Neoplasm Cervical Neoplasm Cervix Uteri Cancer Tumor Of The Cervix Uteri CERCA Uterine Cervical Cancer Neoplasms Cervical Uterine Cervical Neoplasms Cervical Cancers Cancer, Cervical, Somatic Malignant Tumor Of Cervix Cervix Carcinoma
Amyotrophic Lateral Sclerosis 1	Amyotrophic Lateral Sclerosis ALS Lou Gehrig Disease Amyotrophic Lateral Sclerosis Type 1 Charcot Disease ALS1 Amyotrophic Lateral Sclerosis, Susceptibility To Fals Lou Gehrig'S Disease Mnd Motor Neuron Disease Familial Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis 1, Familial Amyotrophic Lateral Sclerosis 1, Autosomal Dominant Motor Neuron Disease, Bulbar Motor Neurone Disease Amyotrophic Lateral Sclerosis With Dementia Dementia With Amyotrophic Lateral Sclerosis Motor Neuron Disease, Amyotrophic Lateral Sclerosis Sclerosis, Lateral, Amyotrophic Sclerosis, Lateral, Amyotrophic, Type 1 Amyotrophic Sclerosis Als - [Amyotrophic Lateral Sclerosis] Wasting Palsy Amyotrophic Paralysis Amyotrophy Lateral Sclerosis Wasting Paralysis Spinal Progressive Amyotrophy Progressive Atrophic Paralysis
Hemimegalencephaly	Unilateral Megalencephaly Macrencephaly
Klippel-Trenaunay-Weber Syndrome	Klippel-Trenaunay Syndrome KTS Ktw Syndrome Angioosteohypertrophy Syndrome Angio-Osteohypertrophy Syndrome Klippel Trenaunay Syndrome Klippel-Trénaunay-Weber Syndrome Haemangiectatic Hypertrophy Weber-Klippel-Trenaunay Congenital Dysplastic Angiopathy Klippel-Trenaunay Disease Weber Klippel Trenaunay
Hyperphosphatemia
Megalencephaly	Macroencephaly Macrencephaly
Endometrial Hyperplasia
Polycystic Kidney Disease 1 With Or Without Polycystic Liver Disease	Polycystic Kidney Disease 1 PKD1 Adpkd Polycystic Kidney Disease, Adult, Type I Apkd1 Potter Type Iii Polycystic Kidney Disease Polycystic Kidney Disease, Adult Potter Type Iii Polycystic Kidney Disease, Formerly Polycystic Kidney Disease, Type 1 Adpkd1 Adult Polycystic Kidney Disease Type 1 Autosomal Dominant Polycystic Kidney Disease 1 Pkd-1 Polycystic Kidney Disease Adult Polycystic Kidney Disease Type I Polycystic Kidneys Polycystic Kidney Disease, Adult Type I Polycystic Kidney Type 1 Autosomal Dominant Disease Kidney Disease, Polycystic, Type 1 Polycystic Kidney, Autosomal Dominant Polycystic Kidney, Type 1 Autosomal Dominant Disease Polycystic Kidney Diseases
Dilated Cardiomyopathy	Familial Dilated Cardiomyopathy Primary Dilated Cardiomyopathy Idiopathic Dilated Cardiomyopathy Congestive Cardiomyopathy Idiopathic Dilation Cardiomyopathy Primary Familial Dilated Cardiomyopathy Cardiomyopathy, Dilated DCM Cardiomyopathy, Familial Dilated Dilated Cardiomyopathy, Familial Hypokinetic Dilated Cardiomyopathy, Familial Familial Idiopathic Cardiomyopathy Fdc Cardiomyopathy, Familial Idiopathic Idiopathic Cardiomegaly Dilated Congestive Cardiomyopathy Chronic Dilated Cardiomyopathy Ccm - [Congestive Cardiomyopathy] Cocm - [Congestive Cardiomyopathy] Dcm - [Dilated Cardiomyopathy] Dilated-Hypokinetic Cardiomyopathy Congestive Idiopathic Cardiomyopathy Primary Idiopathic Dilated Cardiomyopathy
Cowden Syndrome 1	Pten Hamartoma Tumor Syndrome Bannayan-Riley-Ruvalcaba Syndrome Lhermitte-Duclos Disease Bannayan-Zonana Syndrome Phts Riley-Smith Syndrome Bzs Ruvalcaba-Myhre-Smith Syndrome Multiple Hamartoma Syndrome Rmss Brrs Dysplastic Gangliocytoma Of The Cerebellum CWS1 Cs Cd Mham Pten Hamartoma Tumor Syndrome With Granular Cell Tumor Macrocephaly Multiple Lipomas And Hemangiomata Bannayan-Ruvalcaba-Riley Syndrome Myhre-Riley-Smith Syndrome LDD Cerebelloparenchymal Disorder Vi Hamartoma Syndrome, Multiple Bbrs Macrocephaly, Pseudopapilledema, And Multiple Hemangiomata Macrocephaly, Multiple Lipomas, And Hemangiomata Macrocephaly Pseudopapilledema And Multiple Hemangiomas Ruvalcaba -Myhre-Smith Syndrome Ruvalcaba-Myhre Syndrome Cowden Disease Macrocephaly Pseudopapilledema And Multiple Hemangiomata Cerebellar Granule Cell Hypertrophy And Megalencephaly Cpd6 Lhermitte-Duclos Syndrome Pten Hamartoma Tumor Syndromes Cowden Syndrome, Type 1
Smith-Kingsmore Syndrome	Macrocephaly-Intellectual Disability-Neurodevelopmental Disorder-Small Thorax Syndrome Minds Syndrome SKS Macrocephaly, Seizures, Mental Retardation, Umbilical Hernia, And Facial Dysmorphism Macrocephaly, Seizures, Intellectual Disability, Umbilical Hernia, And Facial Dysmorphism
Hematologic Cancer	Hematologic Neoplasm Hematologic Malignancies Hematologic Neoplasms Blood Cancer Hematologic Malignancy Hematological Tumors Hematopoietic And Lymphoid System Tumor Hematopoietic Cancer Hematopoietic Neoplasm Hematopoietic Tumors Malignant Hematopoietic Neoplasm Liquid Tumor Hematopoietic Neoplasms
Body Mass Index Quantitative Trait Locus 11	OBESITY Obesity, Susceptibility To Leanness, Inherited Obesity, Susceptibility To, Bmiq11 Obesity, Mild, Early-Onset Obesity, Association With Obesity, Early-Onset, Susceptibility To Obesity, Severe Obesity, Severe, And Type Ii Diabetes Obesity, Late-Onset BMIQ11 Obesity Bmiq11 Obesity, Early-Onset Obesity , Susceptibility To Simple Obesity Nos Excess Fat Obesity, Not Elsewhere Classified, Body Mass Index Not Elsewhere Classified Adiposis
Endometrial Cancer	Endometrial Carcinoma Endometrial Neoplasm Malignant Neoplasm Of Endometrium Endometrioid Carcinoma Endometrial Neoplasms Carcinoma, Endometrioid Endometrial Cancer, Familial Endometrial Carcinoma, Somatic Endometrial Cancer, Susceptibility To Endometrial Ca Malignant Endometrial Neoplasm Neoplasm Of Endometrium Primary Malignant Neoplasm Of Endometrium Tumor Of Endometrium Carcinoma Of The Endometrium Endometrioid Carcinoma Of Female Reproductive System ENDMC Carcinoma Endometrioid Endometrial Cancers Cancer, Endometrial Uterine Corpus Cancer
Breast Cancer	Breast Carcinoma Breast Cancer, Familial Malignant Neoplasm Of Breast Male Breast Cancer Breast Cancer, Susceptibility To Breast Cancer, Early-Onset Malignant Tumor Of Breast Carcinoma Of Male Breast Breast Cancer, Invasive Ductal Breast Cancer, Protection Against Breast Cancer, Somatic Breast Cancer, Male Breast Cancer, Lobular, Somatic Breast Tumor Mammary Cancer Mammary Tumor Malignant Neoplasm Of Male Breast Mammary Carcinoma Male Breast Carcinoma Familial Cancer Of Breast Invasive Ductal Breast Carcinoma Breast Cancer Susceptibility Breast Cancer, Male, Susceptibility To Breast Cancer, Early-Onset, Susceptibility To Malignant Tumor Of The Breast Mammary Neoplasm Primary Breast Cancer Neoplasm Of Male Breast Carcinoma Of Breast Breast Cancer In Men Familial Breast Cancer Cancer Of Breast BC Breast Cancer Familial Breast Cancer Familial Male Breast Cancer, Familial Male Breast Male Carcinoma Breast Neoplasms Breast Neoplasms, Male Mammary Tumors Mammary Carcinomas Cancer, Breast Cancer, Breast, Susceptibility Invasive Breast Ductal Carcinoma Breast Neoplasm Susceptibility To Breast Cancer Mammary Neoplasms Animal Mammary Neoplasms Primary Malignant Neoplasm Of Breast Infiltrating Ductal Carcinoma Of Breast Infiltrating Duct Carcinoma Of Unspecified Site Infiltrating Ductular Carcinoma Of Unspecified Site Invasive Breast Carcinoma Of No Special Type Microinvasive Carcinoma Of Breast Carcinoma With Apocrine Differentiation
Optic Nerve Glioma	Glioma Of The Optic Nerve
Stomatitis
Neuroendocrine Tumor	Neuroendocrine Neoplasm Neuroendocrine Tumors Carcinoma, Neuroendocrine
Myelofibrosis	Primary Myelofibrosis Agnogenic Myeloid Metaplasia Idiopathic Myelofibrosis Myeloid Metaplasia Myelofibrosis With Myeloid Metaplasia Osteomyelofibrosis Megakaryocytic Myelosclerosis Myelosclerosis Chronic Idiopathic Myelofibrosis Myelofibrosis, Idiopathic Myelofibrosis With Myeloid Metaplasia, Somatic Myelofibrosis, Somatic Aleukemic Myelosis Bone Marrow Fibrosis MYELOF MMM Agnogenic Myeloid Metaplasia With Myelofibrosis Ammm Myelosclerosis With Myeloid Metaplasia Myelofibrosis Nos
Neurofibromatosis, Type I	Von Recklinghausen Disease Neurofibromatosis 1 Neurofibromatosis, Type 1 NF1 Neurofibromatosis, Peripheral Type Neurofibromatosis Type I Neurofibromatosis Type 1 Due To Nf1 Mutation Or Intragenic Deletion Familial Spinal Neurofibromatosis Fsnf Peripheral Neurofibromatosis Von Recklinghausen'S Neurofibromatosis Von Recklinghausen Disease Due To Nf1 Mutation Or Intragenic Deletion Neurofibromatosis Peripheral Type Von Recklinghausen Syndrome Neurofibromatosis Type 1 Von Recklinghausen Neuropathy Nf1 - [Neurofibromatosis Type 1] Recklinghausen Disease
Esophageal Cancer	Esophageal Carcinoma Carcinoma Of Esophagus Esophageal Squamous Cell Carcinoma, Somatic Esophageal Carcinoma, Somatic Esophagus Cancer Gastric Cardia Adenocarcinoma Esophageal Neoplasms Esophageal Cancer, Somatic Cancer Of Esophagus Cancer Of Oesophagus Carcinoma Of Oesophagus Ca Lower Third Oesophagus Ca Middle Third Oesophagus Malignant Neoplasm Of Distal Third Of Esophagus Malignant Neoplasm Of Lower Third Of Oesophagus Malignant Neoplasm Of Middle Third Of Oesophagus Malignant Neoplasm Of Proximal Third Of Esophagus Malignant Neoplasm Of Upper Third Esophagus Malignant Tumor Of Abdominal Esophagus Malignant Tumor Of Distal Third Of Esophagus Malignant Tumor Of Proximal Third Of Esophagus Malignant Tumor Of The Middle Third Of The Esophagus ESCR Aerodigestive Tract Cancer Escc Esophageal Squamous Cell Carcinoma Cancer, Esophageal Malignant Neoplasm Of Esophagus Squamous Cell Carcinoma Of Esophagus Malignant Neoplasm Of Middle Third Of Esophagus
Polycystic Kidney Disease 4 With Or Without Polycystic Liver Disease	Autosomal Recessive Polycystic Kidney Disease Arpkd Polycystic Kidney Disease, Autosomal Recessive Polycystic Kidney And Hepatic Disease 1 Pkhd1 PKD4 Polycystic Kidney Disease 4 With Or Without Hepatic Disease Polycystic Kidney Disease, Infantile, Type I Polycystic Kidney Disease, Infantile Type Polycystic Kidney, Autosomal Recessive Pkd3, Formerly Polycystic Kidney Disease 4, With Or Without Hepatic Disease Arpkd/Chf Ar-Pkd Polycystic Kidney Disease 4, With Or Without Polycystic Liver Disease Infantile Polycystic Kidney Disease Type I Pkd3 Kidney, Polycystic, Disease, Type 4, With/Without Hepatic Disease Polycystic Kidney Disease 3, Autosomal Dominant
Subependymal Giant Cell Astrocytoma	Sega Astrocytoma Subependymal Giant Cell Subependymal Giant-Cell Astrocytoma
Angelman Syndrome	AS Happy Puppet Syndrome Happy Puppet Syndrome, Formerly Puppetlike Syndrome
Type 2 Diabetes Mellitus	Insulin Resistance NIDDM Diabetes Mellitus, Non-Insulin-Dependent Type 2 Diabetes T2D Noninsulin-Dependent Diabetes Mellitus Diabetes Mellitus, Type Ii Maturity-Onset Diabetes Insulin Resistance, Severe, Digenic Diabetes Mellitus, Type 2 Diabetes Mellitus, Noninsulin-Dependent Diabetes Mellitus, Noninsulin-Dependent, Association With Diabetes Mellitus, Noninsulin-Dependent, Late Onset Hypertension, Insulin Resistance-Related, Susceptibility To Insulin Resistance, Susceptibility To Non-Insulin-Dependent Diabetes Mellitus Type Ii Diabetes Mellitus Adult-Onset Diabetes Mellitus Maturity-Onset Diabetes Mellitus Diabetes Mellitus Type 2 Type Ii Diabetes Type 2 Diabetes Mellitus, Susceptibility To Diabetes, Type 2 Diabetes Mellitus, Noninsulin-Dependent, Susceptibility To Diabetes Mellitus, Non-Insulin-Dependent, Susceptibility To Diabetes Mellitus, Type 2, Susceptibility To Diabetes Mellitus, Noninsulin-Dependent, 2 Diabetes Mellitus, Type Ii, Susceptibility To Hypertension, Insulin Resistance-Related Adult-Onset Diabetes Aodm Diabetes Mellitus, Adult-Onset Diabetes Mellitus Type Ii Diabetes Mellitus Type 2, Susceptibility To Diabetes, Type Ii, Susceptibility To Diabetes Type 2 Diabetes Mellitus Adult Onset Diabetes Maturity Onset Diabetes Nonketotic Diabetes Non-Insulin Dependent Diabetes Mellitus T2dm - [Type 2 Diabetes Mellitus] Niddm - [Non Insulin Dependent Diabetes Mellitus] Dm2 Dm Type Ii Diabetic Type 2 Insulin Requiring Type 2 Diabetes Noninsulin Dependent Diabetes Non-Insulin-Dependent Diabetes Mellitus Without Complications Diabetes Due To Insulin Secretory Defect Diabetes Mellitus Due To Insulin Secretory Defect Non-Insulin-Dependent Diabetes Of The Young Senile Diabetes Nonketotic Hyperglycaemia Stable Diabetes
Proteus Syndrome	Proteus Syndrome, Somatic Partial Gigantism-Nevi-Hemihypertrophy-Macrocephaly Syndrome Gigantism, Partial, Of Hands And Feet, Nevi, Hemihypertrophy, And Macrocephaly Wiedemann'S Syndrome Hemihypertrophy And Macrocephaly Partial Gigantism Of Hands And Feet, Nevi, Hemihypertrophy, Macrocephaly Ps PROTEUSS Partial Gigantism Of Hands And Feet Nevi Hemihypertrophy And Macrocephaly
Lung Cancer	Lung Carcinoma Non-Small Cell Lung Carcinoma Lung Cancer, Protection Against Lung Cancer, Susceptibility To Adenocarcinoma Of Lung, Somatic Nonsmall Cell Lung Cancer Adenocarcinoma Of Lung, Response To Tyrosine Kinase Inhibitor In Lung Neoplasm Carcinoma Of Lung Lung Non-Small Cell Carcinoma Non-Small Cell Lung Cancer Nsclc Lung Neoplasms Malignant Neoplasm Of Lung Alveolar Cell Carcinoma Nonsmall Cell Lung Cancer, Somatic Nonsmall Cell Lung Cancer, Response To Tyrosine Kinase Inhibitor In Nonsmall Cell Lung Cancer, Susceptibility To Lung Cancer, Somatic Lung Cancer, Resistance To Cancer Of Lung Cancer Of Bronchus Cancer Of The Lung Lung Malignancies Lung Malignant Tumors Malignant Lung Tumor Malignant Tumor Of Lung Pulmonary Cancer Pulmonary Carcinoma Pulmonary Neoplasms Respiratory Carcinoma LNCR Adenocarcinoma Of Lung Neoplasm Of Lung Cancer Lung Carcinoma Non-Small Cell Lung Carcinoma, Non-Small-Cell Lung Lung Cancers Lung Carcinomas Cancer, Lung Cancer, Lung, Non-Small Cell Primary Malignant Neoplasm Of Lung Bronchioloalveolar Adenocarcinoma
Vaginal Adenosarcoma
Congenital Nervous System Abnormality	Congenital Neurologic Anomaly Congenital Nervous System Disorder
Retinitis Pigmentosa	RP Rod-Cone Dystrophy Autosomal Recessive Retinitis Pigmentosa Non-Syndromic Retinitis Pigmentosa Pericentral Pigmentary Retinopathy Pigmentary Retinopathy Tapetoretinal Degeneration Rcd Retinitis Pigmentosa Autosomal Recessive ARRP Retinitis Pigmentosa, Autosomal Recessive Retinitis Pigmentosa 1
Adult Malignant Schwannoma	Adult Mpnst Adult Neurofibrosarcoma
Renal Cell Carcinoma, Papillary, 1	Papillary Renal Cell Carcinoma Hereditary Papillary Renal Cell Carcinoma Papillary Renal Cell Carcinoma, Sporadic Papillary Renal Cell Adenocarcinoma RCCP RCCP1 Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Papillary, 1, Familial And Somatic Chromophil Carcinoma Of Kidney Papillary Kidney Carcinoma Sporadic Papillary Renal Cell Carcinoma Chromophil Renal Cell Carcinoma Papillary Renal Carcinoma, Malignant - Papillary Renal Cell Carcinoma, Bilateral - Papillary Renal Cell Carcinoma, Familial - Papillary Renal Cell Carcinoma, Multiple - Papillary Renal Cell Carcinoma, Sporadic - Renal Adenocarcinoma Chromophil Rcc Hprcc Renal Cell Carcinoma Papillary Chromophilic Renal Cell Carcinoma Prcc Carcinoma, Renal Cell, Papillary, Type 1 Type 1 Papillary Renal Cell Carcinoma Renal Cell Carcinoma Hereditary Papillary Renal Carcinoma
Thymus Gland Disease	Disease Of Thymus Gland
Von Hippel-Lindau Syndrome	Von Hippel-Lindau Disease Vhl Vhl Syndrome VHLS Von Hippel-Lindau Syndrome, Modifier Of Hippel Lindau Syndrome Angiomatosis Retinae Cerebelloretinal Angiomatosis, Familial Hippel-Lindau Disease Familial Cerebelloretinal Angiomatosis Lindau Disease VHLD
Heart Disease	Heart Failure Congenital Heart Disease Heart Diseases Congenital Heart Defects Congenital Heart Defect Congenital Anomaly Of Heart Heart Defect Heart Malformation Heart-Congenital Defect Congenital Heart Disorder Heart Defects Congenital Heart Defects, Congenital Heart Defects Heart Disease, Congenital Disease, Heart, Congenital Congestive Heart Failure
Mantle Cell Lymphoma	Lymphoma, Mantle Cell Lcm Mcl Mantle Zone Lymphoma Lymphoma Mantle-Cell Lymphoma, Mantle-Cell Malignant Lymphoma, Lymphocytic, Intermediate Differentiation, Diffuse Malignant Lymphoma - Lymphocytic, Intermediate Differentiation Diffuse Small Cleaved-Cell Lymphoma Diffuse Small Cleaved Cell Malignant Lymphoma Small Cleaved Cell Non-Hodgkin Lymphoma Diffuse Non-Hodgkin Small Cleaved Cell Lymphoma Malignant Lymphomatous Polyposis Malignant Small Cell, Noncleaved, Diffuse Lymphoma Malignant Undifferentiated Cell, Non-Burkitt Lymphoma Cleaved Cell Lymphoma Small Cell Mantle Cell Lymphoma Small Cleaved Cell Malignant Lymphoma
Hepatocellular Carcinoma	Liver Cancer Primary Liver Cancer HCC Hepatoma Malignant Neoplasm Of Liver Liver Neoplasms Cancer, Hepatocellular Liver Cell Carcinoma Lcc Hepatoblastoma, Somatic Hepatic Cancer Primary Malignant Neoplasm Of Liver Rare Tumor Of Liver And Intrahepatic Biliary Tract Hepatocellular Carcinoma, Somatic Hepatocellular Carcinoma, Childhood Type, Somatic Hepatocellular Cancer, Somatic Ca Liver - Primary Hepatic Neoplasm Malignant Hepato-Biliary Neoplasm Malignant Neoplasm Of Liver, Not Specified As Primary Or Secondary Malignant Neoplasm Of Liver, Primary Malignant Tumor Of Liver Neoplasm Of Liver Non-Resectable Primary Hepatic Malignant Neoplasm Resectable Malignant Neoplasm Of Liver Resectable Malignant Neoplasm Of The Liver Primary Liver Carcinoma Primary Malignant Liver Neoplasm Primary Cancer Of Liver Primary Tumor Of The Liver Rare Tumor Of Liver And Ibt Hepatocellular Cancer Neoplasm Of The Liver Hepatomas Liver Neoplasm Liver Carcinoma Liver And Intrahepatic Biliary Tract Carcinoma Malignant Hepatobiliary Neoplasm Adult Primary Hepatocellular Carcinoma Hepatoblastoma Carcinoma Of Liver Malignant Liver Tumour Malignant Hepatic Tumour
Peripheral Nervous System Disease	Peripheral Neuropathy Peripheral Nerve Disease Peripheral Nerve Disorders Neuropathy, Peripheral Peripheral Neuropathy Due To Vitamin Pyridoxine Hyperalimentation
Rare Genetic Intellectual Disability
Benign Ependymoma	Ependymoma Epithelial Ependymoma Who Grade Ii Ependymal Tumor Myxopapillary Ependymoma
Autosomal Dominant Polycystic Kidney Disease	Polycystic Kidney Disease, Adult Type Adpkd Polycystic Kidney Diseases Polycystic Kidney, Autosomal Dominant Congenital Biliary Ectasias Polycystic Kidney And Hepatic Disease 1 Polycystic Kidney Disease, Autosomal Dominant Kidney, Polycystic, Disease, Autosomal Dominant Adult Polycystic Kidney Disease Polycystic Kidney, Adult Type Apckd - [Autosomal Polycystic Kidney Disease]
Status Epilepticus	Grand Mal Status Epilepticus Grand Mal Status Gcse Generalized Convulsive Status Epilepticus Se Epilepsy With Status Epilepticus
Chordoma	CHDM Notochordoma Notochordal Sarcoma Chordoma, Susceptibility To Chordocarcinoma Chordoepithelioma
Premature Menopause	Primary Ovarian Insufficiency Premature Ovarian Failure Hypergonadotropic Hypogonadism Premature Ovarian Insufficiency Menopause - Premature Menopause Praecox Menopause Premature Menopause, Premature Female Hypergonadotropic Hypogonadism Hypergonadotrophic Ovarian Failure Primary Female Hypogonadism Pof - [Premature Ovarian Failure] Ovarian Failure Ovarian Secretion Suppression Ovary Hyposecretion Ovary Secretion Deficiency Premature Menopause Nos
Nevus, Epidermal	Epidermal Nevus Woolly Hair Nevus Epidermal Naevus Epidermal Nevus Syndrome Nevus, Keratinocytic, Nonepidermolytic Epidermal Nevus, Somatic Nevus, Epidermal, Somatic Nevus Sebaceous Or Woolly Hair Nevus, Somatic Nonepidermolytic Keratinocytic Nevus Epidermal Hamartoma Syndrome Wooly Hair Nevus Keratinocytic Non-Epidermolytic Nevus KNEN Pigmented Moles Organoid Nevus Phakomatosis Nevus Sebaceous Melanocytic Nevus Melanocytic Nevus Of Skin
Kidney Benign Neoplasm	Renal And Ureteral Tumor Benign Kidney Neoplasm
Childhood Kidney Angiomyolipoma	Pediatric Renal Angiomyolipoma
Polycystic Kidney Disease	Polycystic Kidney Diseases Pkd Polycystic Renal Disease Kidney Disease, Polycystic Polycystic Kidney, Autosomal Dominant
Uterine Corpus Endometrial Carcinoma
Intestinal Obstruction	Inspissated Milk Syndrome Milk Curd Syndrome
Cholangiocarcinoma	Cholangiocarcinoma, Susceptibility To Extrahepatic Cholangiocarcinoma Intrahepatic Cholangiocarcinoma Chlc Chlc, Susceptibility To Cc Cholangiocarcinoma Of Biliary Tract Cholangiocellular Carcinoma Distal Cholangiocarcinoma Perihilar Cholangiocarcinoma Bile Duct Cancer Cca Adult Primary Cholangiocellular Carcinoma Bile Duct Carcinoma
Pancreatic Adenocarcinoma	Adenocarcinoma Of Pancreas Adenocarcinoma Of The Pancreas Pancreas Adenocarcinoma Malignant Exocrine Neoplasm Primary Pancreatic Adenocarcinoma Adenocarcinoma Of Islet Cell Of Pancreas Islet Cell Adenocarcinoma Of Unspecified Site Mixed Adenocarcinoma Islet Cell With Exocrine Of Unspecified Site
Neuroblastoma	Nb Neuroblastoma, Susceptibility To Neuroblastomas Central Neuroblastoma
Alzheimer Disease, Familial, 1	Alzheimer Disease Alzheimer'S Disease Presenile And Senile Dementia AD1 Alzheimer Disease, Susceptibility To Alzheimer Disease, Late-Onset, Susceptibility To Alzheimer Disease 1, Familial AD Familial Alzheimer Disease Alzheimer Disease, Late-Onset Alzheimers Dementia Alzheimer Dementia Alzheimer Sclerosis Alzheimer Syndrome Alzheimer-Type Dementia Dat Primary Senile Degenerative Dementia Sdat Alzheimer Disease 1 Autosomal Dominant Alzheimer Disease Early-Onset Alzheimer Disease With Cerebral Amyloid Angiopathy Late Onset Alzheimer Disease Alzheimers Disease Alzheimer Disease, Early-Onset, With Cerebral Amyloid Angiopathy Late-Onset Alzheimers Disease Alzheimer'S Disease Pathway Kegg Dementia Due To Alzheimer'S Disease Alzheimer Disease Type 1 Alzheimers
Schizophrenia	SCZD Schizophrenia With Or Without An Affective Disorder Schizophrenia 12 Schizophrenia, Susceptibility To Schizophrenia-1 Dementia Praecox Schizophrenia 1
Giant Cell Glioblastoma	Monstrocellular Sarcoma
Mucositis	Inflammatory Disease Of Mucous Membrane Gastrointestinal Mucositis
Castleman Disease	Angiofollicular Ganglionic Hyperplasia Angiofollicular Lymph Hyperplasia Giant Lymph Node Hyperplasia Castleman'S Disease Angiofollicular Lymph Node Hyperplasia Lymphoid Hamartoma Benign Giant Lymphoma Angiolymphoid Hyperplasia
Systemic Lupus Erythematosus	Lupus Nephritis SLE Disseminated Lupus Erythematosus Systemic Lupus Erythematosus, Susceptibility To Lupus Erythematosus, Systemic Lupus Nephritis, Susceptibility To Libman-Sacks Disease Systemic Lupus Erythematosus Susceptibility To Sle - Lupus Erythematosus, Systemic Le Syndrome Lupus Lupus Erythematosus Systemic Lupus Erythematosus, Systemic, Susceptibility To Lupus Vulgaris Lupus Erythematosus, Discoid Lupus Erythematosus Systemic Lupus Erythematosus Nos Sle - [Systemic Lupus Erythematosus]
Lymphoproliferative Syndrome	Lymphoproliferative Disorder Lymphoproliferative Disorders Lymphoproliferative Disorders, Susceptibility To
Lymphoid Interstitial Pneumonia	Lip Disease Lymphocytic Interstitial Pneumonia Lip Diseases LIP Disease Of Lips
Prostate Cancer	Prostate Carcinoma Prostate Cancer, Familial Prostate Neoplasm Prostate Cancer, Somatic Prostate Cancer, Susceptibility To Prostatic Cancer Prostatic Neoplasms Hereditary Prostate Cancer Prostatic Neoplasm Cancer Of Prostate Carcinoma Of Prostate Familial Prostate Cancer Familial Prostate Carcinoma Malignant Tumor Of Prostate Malignant Neoplasm Of Prostate Prostate Cancer, Familial, Susceptibility To Malignant Tumor Of The Prostate Ngp - New Growth Of Prostate Tumor Of The Prostate Prostate Cancer, Hereditary Cancer Of The Prostate Malignant Neoplasm Of The Prostate Prostatic Carcinoma PC Prca Cancer, Prostate Malignant Prostatic Tumour Malignant Tumour Of Prostate Primary Prostate Cancer Primary Malignant Neoplasm Of Prostate Prostate Gland Cancer
Birt-Hogg-Dube Syndrome	Hornstein-Knickenberg Syndrome Fibrofolliculomas With Trichodiscomas And Acrochordons BHD Birt-Hogg-Dubé Syndrome Multiple Fibrofolliculoma Familial Bhd Syndrome Birt Hogg Dube Syndrome Hornstein-Birt-Hogg-Dubé Syndrome Multiple Fibrofolliculomas
Ovarian Cancer	Ovarian Carcinoma Ovarian Neoplasm Malignant Tumour Of Ovary Epithelial Ovarian Cancer Neoplasm Of Ovary Ovarian Neoplasms Ovarian Cancers Malignant Neoplasm Of Ovary Primary Malignant Neoplasm Of Ovary Ovarian Cancer, Somatic Malignant Ovarian Tumor Ovary Neoplasm Primary Ovarian Cancer Tumor Of The Ovary Cancer Of The Ovary Malignant Neoplasm Of The Ovary Malignant Tumor Of The Ovary Ovarian Malignant Tumor OC Ovarian Carcinomas Cancer, Ovarian Cancer Of Ovary Ovary Cancer Ca Ovary
Blood Platelet Disease	Platelet Disorder Blood Platelet Disorders Thrombocytopathy Platelet Dysfunction Platelet Disorders Qualitative Platelet Deficiency
Perivascular Epithelioid Cell Tumor	Pecoma Perivascular Epithelioid Cell Neoplasms Neoplasm With Perivascular Epithelioid Cell Differentiation
Kidney Cancer	Renal Cancer Renal Carcinoma Kidney Neoplasm Malignant Neoplasm Of Kidney Except Pelvis Malignant Tumour Of Kidney Kidney Neoplasms Cancer, Kidney Cancer, Renal Malignant Neoplasm Of Kidney Renal Cell Carcinoma
Leukemia, Chronic Lymphocytic	Chronic Lymphocytic Leukemia B-Cell Chronic Lymphocytic Leukemia CLL B-Cell Chronic Lymphoid Leukemia Chronic Lymphatic Leukemia Chronic Lymphocytic Leukaemia Lymphoplasmacytic Leukemia Small Lymphocytic Lymphoma Leukemia, Chronic Lymphatic B-Cell Chronic Lymphocytic Leukaemia Chronic Lymphatic Leukaemia Lymphoplasmacytic Leukaemia B Cell Chronic Lymphocytic Leukemia Chronic B-Cell Lymphocytic Leukemia Leukemia, Lymphocytic, Chronic B-Cll Chronic Lymphoid Leukemia Leukemia Lymphocytic Chronic Lymphoma Small Lymphocytic Leukemia, Lymphocytic, Chronic, B-Cell

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Approval
Clinical Phase
Pre-clinical Phase

Approval

Bioactive Molecules (32)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-10219	Rapamycin	Inhibitor	99.94%	Yes
HY-B0627	Metformin	Inhibitor	99.98%	Yes
HY-10218	Everolimus	Inhibitor	99.85%	Yes
HY-17471A	Metformin hydrochloride	Inhibitor	99.98%	Yes
HY-N0486	L-Leucine	Activator	99.79%	Unkown
HY-Y0252	L-Proline	Activator	99.75%	Unkown
HY-50910	Temsirolimus	Inhibitor	99.56%	Yes
HY-B0298A	Clemastine fumarate	Activator	99.96%	Yes
HY-16397A	Phenformin hydrochloride	Inhibitor	99.64%	Unkown
HY-W019894	Manganese chloride	Activator	99.1%	Unkown
HY-16397	Phenformin	Inhibitor	98.02%	Unkown
HY-N0281	Daphnetin	Inhibitor	99.77%	Unkown
HY-N0390R	L-Glutamine (Standard)	Inhibitor	98.59%	Unkown
HY-10219R	Rapamycin (Standard)	Inhibitor	98.98%	Unkown
HY-B0766	Bicyclol		99.91%	Unkown
HY-14668	Lomitapide mesylate	Inhibitor	99.61%	Yes
HY-17471AR	Metformin hydrochloride (Standard)	Inhibitor	99.97%	Unkown
HY-B0298	Clemastine	Activator	99.26%	Yes
HY-B0319	Tioconazole	Inhibitor	99.90%	Unkown
HY-N6951	Guaiazulene	Inhibitor	99.08%	Unkown
HY-10218R	Everolimus (Standard)	Inhibitor	99.27%	Unkown
HY-128932	Cefminox sodium		99.83%	Unkown
HY-B0168B	Levomilnacipran hydrochloride	Activator	99.95%	Unkown
HY-B0921	Succinylsulfathiazole	Inhibitor	99.75%	Unkown
HY-B0725A	Doxepin		99.66%	Yes
HY-15960	PWT-33597 free base	Inhibitor	/	Unkown
HY-15960A	PWT-33597	Inhibitor	/	Unkown
HY-B1232A	Metyrapone Tartrate	Modulator	/	Unkown
HY-14794A	Levomilnacipran	Activator	/	Unkown
HY-B0298AR	Clemastine fumarate (Standard)	Activator	/	Unkown
HY-16397AR	Phenformin hydrochloride (Standard)	Inhibitor	/	Unkown
HY-16397R	Phenformin (Standard)	Inhibitor	/	Unkown

Inhibitory Antibodies (1)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P9933	Dinutuximab	Inhibitor	≥99.0%	Unkown

Clinical Phase

Bioactive Molecules (45)

Cat. No.	Product Name	Effect	Purity	Phase
HY-131686	Ganglioside GT1b (bovine) ammonium	Activator	98.0%	Phase 4
HY-B0627A	Metformin (glycinate)	Inhibitor	/	Phase 4
HY-50673	Dactolisib	Inhibitor	99.94%	Phase 3
HY-10681	Gedatolisib	Inhibitor	99.89%	Phase 3
HY-19962	Paxalisib	Inhibitor	99.51%	Phase 3
HY-15174	Dactolisib Tosylate	Inhibitor	99.87%	Phase 3
HY-139142B	Simufilam hydrochloride	Inhibitor	99.85%	Phase 3
HY-139142	Simufilam	Inhibitor	99.78%	Phase 3
HY-16728	Rapastinel	Activator	99.78%	Phase 3
HY-B1787	Sulindac sulfone	Inhibitor	98.10%	Phase 3
HY-139142A	Simufilam dihydrochloride	Inhibitor	/	Phase 3
HY-50876	Daporinad	Inhibitor	99.91%	Phase 2
HY-13328	Sapanisertib	Inhibitor	99.88%	Phase 2
HY-N0112	Dihydromyricetin	Inhibitor	99.73%	Phase 2
HY-139609	Camonsertib	Inhibitor	99.99%	Phase 2
HY-15177	PF-04691502	Inhibitor	99.33%	Phase 2
HY-N9481	Lipoteichoic acid	Inhibitor	/	Phase 2
HY-12513	Samotolisib	Inhibitor	98.85%	Phase 2
HY-13246	Apitolisib	Inhibitor	99.29%	Phase 2
HY-12868	Bimiralisib	Inhibitor	98.62%	Phase 2
HY-13334A	BGT226	Inhibitor	99.85%	Phase 2
HY-10423	OSI-027	Inhibitor	99.95%	Phase 2
HY-16956	Onatasertib	Inhibitor	99.47%	Phase 2
HY-15900	Voxtalisib	Inhibitor	99.82%	Phase 2
HY-13334	BGT226 maleate	Inhibitor	99.92%	Phase 2
HY-109179	Itacnosertib	Inhibitor	99.06%	Phase 2
HY-13691	MKC-1	Inhibitor	99.78%	Phase 2
HY-13610	N1,N11-Diethylnorspermine	Inhibitor	/	Phase 2
HY-10358	MK-2206 dihydrochloride	Inhibitor	99.99%	Phase 1
HY-10422	AZD-8055	Inhibitor	99.60%	Phase 1
HY-10297	Omipalisib	Inhibitor	99.94%	Phase 1
HY-132168	RMC-5552	Inhibitor	99.94%	Phase 1
HY-16962	CC-115	Inhibitor	99.10%	Phase 1
HY-16585	VS-5584	Inhibitor	98.71%	Phase 1
HY-14774	Monepantel	Inhibitor	99.98%	Phase 1
HY-12036	GSK1059615	Inhibitor	99.76%	Phase 1
HY-16962A	CC-115 hydrochloride	Inhibitor	98.01%	Phase 1
HY-14581	Palomid 529	Inhibitor	99.37%	Phase 1
HY-11080	PKI-179	Inhibitor	98.0%	Phase 1
HY-15248	GDC-0349	Inhibitor	99.10%	Phase 1
HY-126077	MTI-31	Inhibitor	99.98%	Phase 1
HY-124036	DS-7423	Inhibitor	99.83%	Phase 1
HY-137315	TML-6	Inhibitor	98.34%	Phase 1
HY-11080A	PKI-179 hydrochloride	Inhibitor	99.66%	Phase 1
HY-15691A	PF-4455242 hydrochloride	Activator	99.01%	Phase 1

Pre-clinical Phase

Bioactive Molecules (487)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-10071	Y-27632	Inhibitor	99.91%	Unkown
HY-B0795	MHY1485	Activator	99.93%	Unkown
HY-13003	Torin 1	Inhibitor	99.28%	Unkown
HY-N0171A	Beta-Sitosterol (purity>98%)	Agonist	99.74%	Unkown
HY-N0390S1	L-Glutamine-13C5	Inhibitor	99.93%	Unkown
HY-N0109	Salidroside	Activator	99.88%	Unkown
HY-13002	Torin 2	Inhibitor	99.69%	Unkown
HY-112537	D-Glucose 6-phosphate	Activator	99.90%	Unkown
HY-10115	PI-103	Inhibitor	99.82%	Unkown
HY-122022	JR-AB2-011	Inhibitor	98.15%	Unkown
HY-124719	hSMG-1 inhibitor 11j	Inhibitor	99.82%	Unkown
HY-15247	Vistusertib	Inhibitor	99.70%	Unkown
HY-P1410B	D-GsMTx4	Inhibitor	99.44%	Unkown
HY-N0189	Aloe emodin	Inhibitor	98.32%	Unkown
HY-10474	Torkinib	Inhibitor	99.03%	Unkown
HY-N0143	Phlorizin	Inhibitor	99.93%	Unkown
HY-13610A	N1,N11-Diethylnorspermine tetrahydrochloride	Inhibitor	99.82%	Unkown
HY-100542	D-α-Hydroxyglutaric acid disodium	Inhibitor	98.0%	Unkown
HY-108232	MK-2206	Inhibitor	99.72%	Unkown
HY-N0270	Ononin	Inhibitor	99.97%	Unkown
HY-N0022	Isoacteoside	Inhibitor	99.73%	Unkown
HY-W012722	4-Methyl-2-oxopentanoic acid	Inhibitor	99.51%	Unkown
HY-U00434	3BDO	Activator	99.93%	Unkown
HY-111373	RapaLink-1	Inhibitor	99.65%	Unkown
HY-N0047	Polyphyllin I	Inhibitor	99.91%	Unkown
HY-114384	Mefluleucine	Activator	98.0%	Unkown
HY-N0787	Cryptochlorogenic acid	Inhibitor	99.87%	Unkown
HY-106591A	4-Vinylcyclohexene dioxide	Activator	98.57%	Unkown
HY-N0486S9	L-Leucine-d3	Activator	99.98%	Unkown
HY-155864	AJ2-30	Inhibitor	99.85%	Unkown
HY-N0390S8	L-Glutamine-15N2	Inhibitor	99.95%	Unkown
HY-155747	FDW028	Inhibitor	99.51%	Unkown
HY-W011927	4,4'-Sulfonyldiphenol	Agonist	99.81%	Unkown
HY-N0390S	L-Glutamine-15N	Inhibitor	99.6%	Unkown
HY-124798	Rheb inhibitor NR1	Inhibitor	99.26%	Unkown
HY-P1410C	D-GsMTx4 TFA	Inhibitor	99.89%	Unkown
HY-124760	hSMG-1 inhibitor 11e	Inhibitor	99.94%	Unkown
HY-116522	AR420626		98.40%	Unkown
HY-50710	KU-0063794	Inhibitor	99.67%	Unkown
HY-134508	C24-Ceramide	Activator	99.92%	Unkown
HY-N0390S9	L-Glutamine-15N-1	Inhibitor	98.0%	Unkown
HY-113038	D-α-Hydroxyglutaric acid	Inhibitor	98.0%	Unkown
HY-W142080	α-Methyl-DL-tryptophan	Inhibitor	99.99%	Unkown
HY-N0837	Veratramine	Inhibitor	99.88%	Unkown
HY-155033	SSI-4	Inhibitor	99.99%	Unkown
HY-N0390S2	L-Glutamine-d5	Inhibitor	99.79%	Unkown
HY-N1462	Atractyloside potassium salt	Inhibitor	99.93%	Unkown
HY-N0486S1	L-Leucine-13C	Activator	99.90%	Unkown
HY-114384B	Mefluleucine hydrochloride	Activator	98.0%	Unkown
HY-W592871	10-Hydroxy-2-decenoic acid		99.93%	Unkown
HY-128483	Fusaric acid	Inhibitor	99.94%	Unkown
HY-Y0396	N-Hydroxyphthalimide	Inhibitor	99.89%	Unkown
HY-N0404	Sinigrin	Inhibitor	99.97%	Unkown
HY-N0876	Arenobufagin		99.82%	Unkown
HY-N0486S8	L-Leucine-13C6,15N	Activator	99.90%	Unkown
HY-N1437	Hydroxycitric acid	Activator	99.95%	Unkown
HY-N6996	Methyl Eugenol	Inhibitor	99.79%	Unkown
HY-N6626	Pyraclostrobin		99.91%	Unkown
HY-N0819	Raddeanin A	Inhibitor	98.68%	Unkown
HY-112537S1	D-Glucose 6-Phosphate-13C6 (disodium xhydrate)	Activator	99.6%	Unkown
HY-N0486S2	L-Leucine-13C6	Activator	99.64%	Unkown
HY-N1255	Scoulerine	Inhibitor	99.99%	Unkown
HY-N6602	α-Solanine	Inhibitor	99.89%	Unkown
HY-50908	Ridaforolimus	Inhibitor	99.75%	Unkown
HY-N0447	8-Gingerol	Modulator	99.82%	Unkown
HY-168555	YJ1206	Activator	97.26%	Unkown
HY-15521	ETP-46464	Inhibitor	99.54%	Unkown
HY-100398	PF-04979064	Inhibitor	99.93%	Unkown
HY-10044	WYE-132	Inhibitor	99.90%	Unkown
HY-12763	GNE-317	Inhibitor	98.76%	Unkown
HY-N1677	2,6-Dimethoxy-1,4-benzoquinone		98.72%	Unkown
HY-10372	PP121	Inhibitor	99.51%	Unkown
HY-N0390S6	L-Glutamine-13C5,15N2	Inhibitor	98.0%	Unkown
HY-110228	Metformin-d6 hydrochloride	Inhibitor	99.98%	Unkown
HY-W016412	Coenzyme Q0	Inhibitor	99.79%	Unkown
HY-N0657	Pinoresinol Diglucoside		99.84%	Unkown
HY-N0616	Trifolirhizin	Activator	98.37%	Unkown
HY-115449	Chromeceptin	p53 Inhibitor	99.80%	Unkown
HY-18353	mTOR inhibitor-3	Inhibitor	99.79%	Unkown
HY-10683	PKI-402	Inhibitor	99.17%	Unkown
HY-N2541	Gymnemic acid I	Inhibitor	98.59%	Unkown
HY-10115A	PI-103 Hydrochloride	Inhibitor	98.06%	Unkown
HY-13431	KU-0060648	Inhibitor	99.87%	Unkown
HY-N6950	Hederacolchiside A1	Modulator	98.28%	Unkown
HY-N0735	Phellodendrine chloride	Agonist	99.68%	Unkown
HY-134904	RMC-6272	Inhibitor	97.42%	Unkown
HY-139534	ARI-1	Inhibitor	99.16%	Unkown
HY-W130610	Stearamide	Activator	97.0%	Unkown
HY-N0712	Typhaneoside	Activator	99.74%	Unkown
HY-N0885	Telocinobufagin	Inhibitor	99.93%	Unkown
HY-N7400	Phaseoloidin	Activator	99.92%	Unkown
HY-156671	RMC-4998	Inhibitor	99.31%	Unkown
HY-N0107	Cyclovirobuxine D	Inhibitor	99.70%	Unkown
HY-146751	PI3K/Akt/mTOR-IN-2	Inhibitor	99.93%	Unkown
HY-N0486S	L-Leucine-d10	Activator	99.0%	Unkown
HY-N0381	Maackiain	Inhibitor	99.83%	Unkown
HY-W011927S	4,4'-Sulfonyldiphenol-d8	Agonist	99.21%	Unkown
HY-100222	CZ415	Inhibitor	98.39%	Unkown
HY-159480	AD1058	Inhibitor	98.11%	Unkown
HY-N0910	Notoginsenoside Ft1	Inhibitor	99.49%	Unkown
HY-N0656A	(+)-Usnic acid	Inhibitor	99.64%	Unkown
HY-12808	STF-118804	Inhibitor	99.72%	Unkown
HY-N4177	Rubrofusarin gentiobioside	Inhibitor	99.07%	Unkown
HY-P1823	C-Reactive Protein (CRP) (174-185)	Modulator	99.88%	Unkown
HY-N0486S3	L-Leucine-15N	Activator	98.0%	Unkown
HY-174406	MT-125	Activator	98.73%	Unkown
HY-N6983	Licoricesaponin G2		99.87%	Unkown
HY-N0695	Schisantherin B	Inhibitor	99.75%	Unkown
HY-10811	GNE-493	Inhibitor	99.81%	Unkown
HY-111508	PI3K/mTOR Inhibitor-2	Inhibitor	99.10%	Unkown
HY-19763	Ifupinostat	Inhibitor	99.30%	Unkown
HY-N0390S5	L-Glutamine-1-13C	Inhibitor	98.0%	Unkown
HY-N3651	Curzerenone	Inhibitor	98.55%	Unkown
HY-N3677	Dammarenediol II	Inhibitor	99.81%	Unkown
HY-15272	WAY-600	Inhibitor	99.86%	Unkown
HY-112914	mTOR inhibitor-1	Inhibitor	98.82%	Unkown
HY-12034	WYE-354	Inhibitor	98.03%	Unkown
HY-114414	HDACs/mTOR Inhibitor 1	Inhibitor	98.10%	Unkown
HY-112440	HZX-02-059	Inhibitor	99.40%	Unkown
HY-N0008	Orcinol glucoside	Activator	99.40%	Unkown
HY-N0914	Ajugol	Inhibitor	99.80%	Unkown
HY-N0109R	Salidroside (Standard)	Activator	99.82%	Unkown
HY-100026	PQR620	Inhibitor	98.01%	Unkown
HY-136660	PQR626	Inhibitor	99.96%	Unkown
HY-N6843	Arnicolide D	Inhibitor	99.69%	Unkown
HY-162143	SKI-349	Inhibitor	99.48%	Unkown
HY-N2217	Rotundic acid	Inhibitor	99.41%	Unkown
HY-174406A	MT-125 free base	Activator	98.67%	Unkown
HY-16441	Tegafur-gimeracil-oteracil potassium	Inhibitor	99.96%	Unkown
HY-N1163	Tetrahydroalstonine	Activator	99.88%	Unkown
HY-W142432	Perfluoroundecanoic acid	Activator	99.85%	Unkown
HY-100470	NSC781406	Inhibitor	99.97%	Unkown
HY-107365	PQR530	Inhibitor	99.98%	Unkown
HY-10219G	Rapamycin (GMP)	Inhibitor	/	Unkown
HY-131344	mTOR inhibitor-8	Inhibitor	98.14%	Unkown
HY-11095	NPS 2390	Inhibitor	99.90%	Unkown
HY-W338584	Hydroxycitric acid tripotassium	Activator	98.0%	Unkown
HY-N2445	Flavokawain C	Activator	99.79%	Unkown
HY-101955	(2S,6S)-Hydroxynorketamine hydrochloride	Activator	99.30%	Unkown
HY-13806	XL388	Inhibitor	99.57%	Unkown
HY-11042	GNE-477	Inhibitor	98.75%	Unkown
HY-128333	PI3K/mTOR Inhibitor-4	Inhibitor	97.04%	Unkown
HY-118712	WYE-23	Inhibitor	99.24%	Unkown
HY-16728B	Rapastinel Trifluoroacetate	Activator	98.0%	Unkown
HY-W749694	Cannflavin B	Inhibitor	98.36%	Unkown
HY-N1050	Zederone	Inhibitor	99.61%	Unkown
HY-137175	TMBIM6 antagonist-1	Antagonist	98.92%	Unkown
HY-163198	ASCT2-IN-1	Inhibitor	98.21%	Unkown
HY-178164	HBS-101	Inhibitor	99.59%	Unkown
HY-109046	Tulrampator		99.39%	Unkown
HY-W058849	MT 63-78	Inhibitor	98.11%	Unkown
HY-157169	IBL-302	Inhibitor	95.49%	Unkown
HY-179578	SU212	Inhibitor	/	Unkown
HY-N3307	(+)-Medioresinol	Agonist	99.13%	Unkown
HY-N3000	6-Methoxydihydrosanguinarine	Inhibitor	99.88%	Unkown
HY-Y1177	Diphenyl disulfide	Inhibitor	99.96%	Unkown
HY-10219S	Rapamycin-d3	Inhibitor	95.92%	Unkown
HY-151622	PI3K/mTOR Inhibitor-11	Inhibitor	99.65%	Unkown
HY-162382	KTC1101	Inhibitor	98.09%	Unkown
HY-N4315	Pomiferin	Inhibitor	98.01%	Unkown
HY-N4247	Kuwanon G	Inhibitor	99.45%	Unkown
HY-143510	RMC-4627		99.20%	Unkown
HY-10218S	Everolimus-d4	Inhibitor	98.74%	Unkown
HY-10681R	Gedatolisib (Standard)	Inhibitor	97.70%	Unkown
HY-W348485	WRX606	Inhibitor	95.65%	Unkown
HY-N2590	Lupenone		99.74%	Unkown
HY-175646	AGPAT4-IN-1	Inhibitor	99.04%	Unkown
HY-122665	HTH-01-091	Inhibitor	99.81%	Unkown
HY-125927	8-Aminoadenosine	Inhibitor	99.05%	Unkown
HY-130687A	Psicose	Activator	99.90%	Unkown
HY-10219GL	Rapamycin (GMP Like)	Inhibitor	98.8%	Unkown
HY-134903	(32-Carbonyl)-RMC-5552	Inhibitor	95.41%	Unkown
HY-173119	SKLB-D18	Inhibitor	98.06%	Unkown
HY-132902	DEPTOR-IN-1	Inhibitor	98.13%	Unkown
HY-109179A	Itacnosertib hydrochloride	Inhibitor	99.43%	Unkown
HY-107363	FT-1518	Inhibitor	98.62%	Unkown
HY-N6841	Rhodiolin	Inhibitor	98%	Unkown
HY-N2303	Eriocalyxin B	Inhibitor	99.93%	Unkown
HY-176166	PD-M6	Degrader	98.17%	Unkown
HY-153789	PI5P4Kγ-IN-1	Activator	98.82%	Unkown
HY-163199	ASCT2-IN-2	Inhibitor	99.10%	Unkown
HY-156027	SIRT6-IN-3	Inhibitor	98.19%	Unkown
HY-180261	GP262	Degrader	98.43%	Unkown
HY-N0390S4	L-Glutamine-5-13C	Inhibitor	98.0%	Unkown
HY-118717	mTOR inhibitor WYE-28	Inhibitor	99.75%	Unkown
HY-N10303	Withangulatin A	Inhibitor	99.76%	Unkown
HY-10812	GNE-490	Inhibitor	96.79%	Unkown
HY-P10323A	T7 Peptide TFA	Inhibitor	98.20%	Unkown
HY-N2000	Bellidifolin	Modulator	99.74%	Unkown
HY-101349	L 741742	Inhibitor	99.28%	Unkown
HY-N0486S4	L-Leucine-d7	Activator	99.91%	Unkown
HY-N2911	Auriculasin	Inhibitor	98.58%	Unkown
HY-124582	NEO214	Activator	98.0%	Unkown
HY-N5136	25(R,S)-Ruscogenin	Inhibitor	99.83%	Unkown
HY-171047	Autophagy inducer 7	Inhibitor	99.45%	Unkown
HY-121811	Pongamol	Inhibitor	99.81%	Unkown
HY-N11709	Theasaponin E1	Inhibitor	98.68%	Unkown
HY-N9942	Physalin A	Inhibitor	99.63%	Unkown
HY-N6896	Isoviolanthin	Inhibitor	99.87%	Unkown
HY-15271	WYE-687	Inhibitor	98.05%	Unkown
HY-Y0106	2,6-Dihydroxyacetophenone	Inhibitor	99.85%	Unkown
HY-N2896	Arjunolic acid	Activator	98.83%	Unkown
HY-N6932	Voacamine		99.64%	Unkown
HY-N0143A	Phlorizin dihydrate	Inhibitor	99.51%	Unkown
HY-N0390S3	L-Glutamine-13C5,15N2,d5	Inhibitor	99.91%	Unkown
HY-137996	Dehydrovomifoliol	Inhibitor	98.88%	Unkown
HY-10219S1	Rapamycin-13C,d3	Inhibitor	97.05%	Unkown
HY-122949	Momordicine I	Inhibitor	97.0%	Unkown
HY-101776A	Desmethyl-VS-5584 hydrochloride	Inhibitor	98.63%	Unkown
HY-175751	LRK-4189	Modulator	/	Unkown
HY-172423	Darlifarnib	Inhibitor	/	Unkown
HY-176761	NSC647889	Inhibitor	99.28%	Unkown
HY-125953	Ceramide (Egg)		99%	Unkown
HY-114267	Cbz-B3A	Inhibitor	98.63%	Unkown
HY-169960	2DII	Inhibitor	98.92%	Unkown
HY-153120A	PI3K/mTOR Inhibitor-13 sodium	Inhibitor	98.11%	Unkown
HY-15269	PP30	Inhibitor	98.01%	Unkown
HY-N1244	Sarmentosin	Inhibitor	97.0%	Unkown
HY-10681S	Gedatolisib-d8		/	Unkown
HY-N0486S10	L-Leucine-18O2	Activator	98%	Unkown
HY-N12124	Monascuspiloin	Inhibitor	95%	Unkown
HY-N0427	Phellodendrine	Agonist	99.60%	Unkown
HY-N0486S12	L-Leucine-d2	Activator	99.81%	Unkown
HY-10620	PI3K-IN-22	Inhibitor	99.50%	Unkown
HY-175751A	(Rac)-LRK-4189	Inhibitor	96.68%	Unkown
HY-10071A	Y-27632 hydrochloride hydrate	Inhibitor	99.65%	Unkown
HY-174066	SI-W052	Inhibitor	98.0%	Unkown
HY-155066	FD274	Inhibitor	99.45%	Unkown
HY-156671A	RMC-4998 formic	Inhibitor	99.02%	Unkown
HY-110109	ETP-45658	Inhibitor	98.97%	Unkown
HY-162141	MD102	Inhibitor	98.01%	Unkown
HY-147284	PI3K-IN-37	Inhibitor	99.0%	Unkown
HY-12652	AZD3147	Inhibitor	99.93%	Unkown
HY-141805	MHY-1685	Inhibitor	99.84%	Unkown
HY-W654330	Pyraclostrobin-d6		99.90%	Unkown
HY-N0486S6	L-Leucine-2-13C,15N	Activator	98.0%	Unkown
HY-131686A	Ganglioside GT1b (porcine) ammonium	Activator	98%	Unkown
HY-50673A	Dactolisib hydrochloride	Inhibitor	99.41%	Unkown
HY-B0627S	Metformin-d6		98.16%	Unkown
HY-203618	PI3K/mTOR ligand-1	Ligand	97.28%	Unkown
HY-N3628	Coronarin A	Inhibitor	≥98.0%	Unkown
HY-109633A	PI3K/mTOR-IN-23 dihydrochloride	Inhibitor	99.70%	Unkown
HY-N2199	Sotetsuflavone	Inhibitor	96.75%	Unkown
HY-145931	CC214-2	Inhibitor	98.41%	Unkown
HY-109633	PI3K/mTOR-IN-23	Inhibitor	99.0%	Unkown
HY-122665A	HTH-01-091 TFA	Inhibitor	99.48%	Unkown
HY-15271A	WYE-687 dihydrochloride	Inhibitor	≥98.0%	Unkown
HY-W073128	Perfluorotetradecanoic acid	Activator	98.0%	Unkown
HY-P11642A	Sialorphin TFA	Inhibitor	/	Unkown
HY-P3072	Mastoparan 17	Control	98.09%	Unkown
HY-N6651	Isocryptotanshinone	Inhibitor	≥98.0%	Unkown
HY-N2423	Sinigrin hydrate	Inhibitor	99.92%	Unkown
HY-N0390S7	L-Glutamine-15N2,d5	Inhibitor	98%	Unkown
HY-156432	ALK-IN-26	Inhibitor	99.87%	Unkown
HY-123849	SN32976	Inhibitor	99.49%	Unkown
HY-B0298AS	Clemastine-d5 fumarate	Activator	99.79%	Unkown
HY-RS08810	MTOR Human Pre-designed siRNA Set A	Inhibitor	/	Unkown
HY-N2517	Dihydroevocarpine	Inhibitor	99.62%	Unkown
HY-W779800	D-α-Hydroxyglutaric acid-13C5 disodium	Inhibitor	98.87%	Unkown
HY-P11162	FGF7p	Inhibitor	99.34%	Unkown
HY-W114419	Bisphenol C	Inhibitor	≥98.0%	Unkown
HY-U00326	PI3Kα/mTOR-IN-1	Inhibitor	99.30%	Unkown
HY-15174R	Dactolisib Tosylate (Standard)	Inhibitor	98.95%	Unkown
HY-N7521	Procyanidin C2	Inhibitor	/	Unkown
HY-15872	FTI-277	Inhibitor	/	Unkown
HY-W078733	(S)-2-Amino-4,4,4-trifluorobutanoic acid	Modulator	≥98.0%	Unkown
HY-111065	OXA-01	Inhibitor	/	Unkown
HY-15691	PF-04455242	Activator	/	Unkown
HY-115507	NMac1	Inhibitor	/	Unkown
HY-112602	PI3K/mTOR Inhibitor-1	Inhibitor	/	Unkown
HY-151137	HSP90/mTOR-IN-1	Inhibitor	/	Unkown
HY-10357	MK-2206 free base	Inhibitor	/	Unkown
HY-111370	mTOR inhibitor-2	Inhibitor	/	Unkown
HY-150108	RMC-4745	Inhibitor	/	Unkown
HY-W800535	Cryptolepine	Inhibitor	/	Unkown
HY-N3000A	6-Methoxydihydrosanguinarine hydrochloride	Inhibitor	/	Unkown
HY-178812	PI3Kα-IN-27	Inhibitor	/	Unkown
HY-P11656	α-Neoendorphin (porcine)	Modulator	/	Unkown
HY-16397AS	Phenformin-d5 hydrochloride	Inhibitor	/	Unkown
HY-147966	HDAC-IN-43	Inhibitor	/	Unkown
HY-112774	ICSN3250	Inhibitor	/	Unkown
HY-172889	PI3K/HDAC-IN-4	Inhibitor	/	Unkown
HY-184166	COH-17	Inhibitor	/	Unkown
HY-W142432S	Perfluoroundecanoic acid-13C7		/	Unkown
HY-141701	mTOR/HDAC-IN-1	Inhibitor	/	Unkown
HY-178192	mTORC1-IN-3	Inhibitor	/	Unkown
HY-15268	PP487	Inhibitor	/	Unkown
HY-RS08811	Mtor Mouse Pre-designed siRNA Set A	Inhibitor	/	Unkown
HY-144295	PI3Kα-IN-5	Inhibitor	/	Unkown
HY-147613	PI3K/mTOR Inhibitor-6	Inhibitor	/	Unkown
HY-117435	CIDD 0067106	Inhibitor	/	Unkown
HY-P10323	T7 Peptide	Inhibitor	/	Unkown
HY-181650	T133	Inhibitor	/	Unkown
HY-183306	mTOR/STAT3-IN-1	Inhibitor	/	Unkown
HY-153120	PI3K/mTOR Inhibitor-13	Inhibitor	/	Unkown
HY-17654	BIEGi-1	Inhibitor	/	Unkown
HY-D0195R	Acesulfame potassium (Standard)	Modulator	99.89%	Unkown
HY-162147	Nur77 modulator 3	Inhibitor	99.01%	Unkown
HY-179623	PI3Kα-IN-29	Inhibitor	/	Unkown
HY-181059	AMPK/mTOR modulator-1	Inhibitor	/	Unkown
HY-155376	mTOR inhibitor-14	Inhibitor	/	Unkown
HY-152238	PI3K/mTOR Inhibitor-12	Inhibitor	/	Unkown
HY-160548	mTOR inhibitor-18	Inhibitor	/	Unkown
HY-13847	GNE-555	Inhibitor	/	Unkown
HY-125535	OSU-53	Inhibitor	/	Unkown
HY-176948	M-1111	Inhibitor	/	Unkown
HY-144687	ATM Inhibitor-4	Inhibitor	/	Unkown
HY-162589	Lw13	Inhibitor	/	Unkown
HY-177092	AGF347	Inhibitor	/	Unkown
HY-168893	K882	Inhibitor	/	Unkown
HY-P10992	YVPGP	Inhibitor	/	Unkown
HY-176854	PI3K/mTOR-IN-18	Inhibitor	/	Unkown
HY-170670	DQ661	Inhibitor	/	Unkown
HY-118160	PPM-18	Inhibitor	99.17%	Unkown
HY-179388	PROTAC Sirt2 Degrader-2	Inhibitor	/	Unkown
HY-181097	EGFR-IN-192	Inhibitor	/	Unkown
HY-155721	22-(4′-py)-JA	Inhibitor	/	Unkown
HY-168919	KRASG12C IN-16	Inhibitor	/	Unkown
HY-175220	4-TCPA	Inhibitor	/	Unkown
HY-137315S	TML-6-d3		/	Unkown
HY-138976	NV-5440	Inhibitor	/	Unkown
HY-130133	DHW-221	Inhibitor	/	Unkown
HY-181020	Deltafluorine	Inhibitor	/	Unkown
HY-181925	FD2024	Inhibitor	/	Unkown
HY-172816	Carbonic anhydrase inhibitor 32	Inhibitor	/	Unkown
HY-161857	Akt/mTOR-IN-1	Inhibitor	/	Unkown
HY-174382	ROR1-IN-3	Inhibitor	/	Unkown
HY-N6626R	Pyraclostrobin (Standard)		/	Unkown
HY-16728A	Rapastinel acetate	Activator	/	Unkown
HY-RS08812	Mtor Rat Pre-designed siRNA Set A	Inhibitor	/	Unkown
HY-50876A	Daporinad hydrochloride	Inhibitor	/	Unkown
HY-149717	Antitumor agent-122		/	Unkown
HY-154957	mTOR inhibitor-11	Inhibitor	/	Unkown
HY-154958	mTOR inhibitor-12	Inhibitor	/	Unkown
HY-180853	PI3K/Akt/mTOR-IN-6	Inhibitor	/	Unkown
HY-162993	HN2210	Inhibitor	/	Unkown
HY-108338	PF-05139962	Inhibitor	/	Unkown
HY-179457	CC-11	Inhibitor	/	Unkown
HY-183250	eALM1137	Inhibitor	/	Unkown
HY-172259	Toyaburgine	Inhibitor	/	Unkown
HY-172678	PUC-10	Inhibitor	/	Unkown
HY-180056	CAII-IN-12	Inhibitor	/	Unkown
HY-W742805	Sulindac Sulfone-d6		/	Unkown
HY-174855	PI3K/mTOR-IN-17	Inhibitor	/	Unkown
HY-N15121	4-O-Methyl-ascochlorin	Inhibitor	/	Unkown
HY-144686	ATM Inhibitor-3	Inhibitor	/	Unkown
HY-173367	Anticancer agent 271	Inhibitor	/	Unkown
HY-174379	KRAS IN-44	Inhibitor	/	Unkown
HY-119831	Rohitukine	Inhibitor	/	Unkown
HY-159577	Nic-15	Modulator	/	Unkown
HY-180556	PI3K/mTOR-IN-20	Inhibitor	/	Unkown
HY-118704	P-2281	Inhibitor	99.81%	Unkown
HY-147913	PI3K/Akt/mTOR-IN-3	Inhibitor	/	Unkown
HY-168333	5-HT6 inverse agonist 1	Inhibitor	/	Unkown
HY-181491	Tubulin-IN-64	Inhibitor	/	Unkown
HY-163511	PI3K/Akt/mTOR-IN-4	Inhibitor	/	Unkown
HY-161856	Antifungal agent 106	Inhibitor	/	Unkown
HY-179155	PI3K/mTOR-IN-19	Inhibitor	/	Unkown
HY-168609	CRI9	Inhibitor	/	Unkown
HY-154910	CC214-1	Inhibitor	98.49%	Unkown
HY-B0168BS	Levomilnacipran-d5 hydrochloride	Activator	/	Unkown
HY-146016	PI3K/mTOR Inhibitor-5	Inhibitor	/	Unkown
HY-172964	KIM-161	Inhibitor	/	Unkown
HY-16769	Panulisib	Inhibitor	/	Unkown
HY-173493	ALK-IN-31	Inhibitor	/	Unkown
HY-181099	EGFR WT/T790M-IN-4	Inhibitor	/	Unkown
HY-172175	HYS-072	Inhibitor	/	Unkown
HY-101349A	L 741742 hydrochloride	Inhibitor	/	Unkown
HY-176435	mTOR inhibitor-28	Inhibitor	/	Unkown
HY-146200	PI3K/mTOR Inhibitor-8	Inhibitor	/	Unkown
HY-179003	mTOR/GLS1-IN-1	Inhibitor	/	Unkown
HY-159517	PI3K/Akt/mTOR-IN-5	Inhibitor	/	Unkown
HY-181670	WH23	Inhibitor	/	Unkown
HY-121726	3HOI-BA-01	Inhibitor	/	Unkown
HY-173141	mTOR inhibitor-26	Inhibitor	/	Unkown
HY-N0486S13	L-Leucine-15N,d10		/	Unkown
HY-N1338	Royleanone	Inhibitor	/	Unkown
HY-N0486S11	L-Leucine-d1	Activator	/	Unkown
HY-W765245	Rapamycin-13C,d3-1	Inhibitor	/	Unkown
HY-182048	PD-1/PD-L1-IN-62	Modulator	/	Unkown
HY-108959	D-87503	Inhibitor	/	Unkown
HY-178362	CAII/VII-IN-1	Inhibitor	/	Unkown
HY-178431	MT-44	Inhibitor	/	Unkown
HY-101776	Desmethyl-VS-5584	Inhibitor	/	Unkown
HY-P11642	Sialorphin	Inhibitor	/	Unkown
HY-168129	GSK3β/mTOR modulator 1	Inhibitor	/	Unkown
HY-15281	QL-IX-55	Inhibitor	/	Unkown
HY-115869	RMC-4529	Inhibitor	/	Unkown
HY-183327	PI3K/mTOR-IN-22	Inhibitor	/	Unkown
HY-10681S1	Gedatolisib-d6	Inhibitor	/	Unkown
HY-161509	PT-88	Inhibitor	/	Unkown
HY-117767	CZ830	Inhibitor	/	Unkown
HY-170656	PI3K/mTOR Inhibitor-17	Inhibitor	/	Unkown
HY-122352	OSU-03013	Inhibitor	/	Unkown
HY-W550739	Acesulfame	Modulator	/	Unkown
HY-15901	LGB321	Inhibitor	/	Unkown
HY-14794AS	Levomilnacipran-d10 hydrochloride	Activator	/	Unkown
HY-151915	ATR-IN-20	Inhibitor	/	Unkown
HY-156445	PI3K/mTOR Inhibitor-14	Inhibitor	/	Unkown
HY-183272	PI3K/Akt/mTOR-IN-7	Inhibitor	/	Unkown
HY-168884	AV457	Inhibitor	/	Unkown
HY-172789	mTOR inhibitor-27	Inhibitor	/	Unkown
HY-18203	HBF-0079		/	Unkown
HY-147285	PI3K/mTOR Inhibitor-9	Inhibitor	/	Unkown
HY-169022	4-FPBUA	Inhibitor	/	Unkown
HY-N0486S7	L-Leucine-1-13C,15N	Activator	99.93%	Unkown
HY-184487	Anticancer agent 331		/	Unkown
HY-15901A	LGB321 monohydrochloride	Inhibitor	/	Unkown
HY-P5984	Thioether-cyclized helix B peptide, CHBP	Inhibitor	/	Unkown
HY-N13338	Avicin D	Inhibitor	/	Unkown
HY-112537A	D-Glucose 6-phosphate dipotassium	Activator	/	Unkown
HY-181710	LASSBio-2337	Inhibitor	/	Unkown
HY-169407	AKT-IN-24	Inhibitor	/	Unkown
HY-141476	PI3K/mTOR Inhibitor-3	Inhibitor	/	Unkown
HY-183787	PI3Kα-IN-33	Inhibitor	/	Unkown
HY-147614	PI3K/mTOR Inhibitor-7	Inhibitor	/	Unkown
HY-18953	mTOR inhibitor-23	Inhibitor	/	Unkown
HY-179464	CC-M-1	Inhibitor	/	Unkown
HY-170912	Topo I/II-IN-2	Inhibitor	/	Unkown
HY-N0390G	L-Glutamine (GMP)	Inhibitor	/	Unkown
HY-P10833	C-VGB3	Inhibitor	/	Unkown
HY-179502	Anti-inflammatory agent 107	Inhibitor	/	Unkown
HY-179032	VEGFR-2-IN-77	Inhibitor	/	Unkown
HY-W339757	Dioctanoylphosphatidic acid sodium		/	Unkown
HY-128027	eCF309	Inhibitor	98.2%	Unkown
HY-183631	PM54-1	Inhibitor	/	Unkown
HY-144449	mTOR/HDAC6-IN-1	Inhibitor	/	Unkown
HY-N1255A	Scoulerine hydrochloride	Inhibitor	/	Unkown
HY-183307	mTOR-IN-29	Inhibitor	/	Unkown
HY-10116	PI-540	Inhibitor	/	Unkown
HY-184282	Mitochondrial complex I-IN-1	Inhibitor	/	Unkown
HY-112774A	ICSN3250 hydrochloride	Inhibitor	/	Unkown
HY-N0404R	Sinigrin (Standard)	Inhibitor	/	Unkown
HY-112537S2	D-Glucose 6-phosphate-13C	Activator	/	Unkown
HY-127067	Yuanhuadin	Inhibitor	/	Unkown
HY-150061	NVP-BBD130	Inhibitor	/	Unkown
HY-185460	Pertuzumab-LD3	Inhibitor	/	Unkown
HY-P5984A	Thioether-cyclized helix B peptide, CHBP TFA	Inhibitor	/	Unkown
HY-120406	PLS-123	Inhibitor	/	Unkown
HY-N0486S5	L-Leucine-2-13C	Activator	98%	Unkown
HY-156671B	RMC-4998 TFA	Inhibitor	99.02%	Unkown
HY-184167	COH-19	Inhibitor	/	Unkown
HY-169100	Antiproliferative agent-57		/	Unkown
HY-170405	YB-3–17	Inhibitor	/	Unkown
HY-N2217R	Rotundic acid (Standard)	Inhibitor	/	Unkown
HY-174141	LP-65	Inhibitor	/	Unkown
HY-W783478	Calebin A	Inhibitor	98.0%	Unkown
HY-139832	MCX 28	Inhibitor	/	Unkown
HY-N0112S	Dihydromyricetin-d4	Inhibitor	/	Unkown
HY-N15267	Ovalitenone	Inhibitor	/	Unkown
HY-185456	PI3K/mTOR-IN-21	Inhibitor	/	Unkown
HY-162025	mTOR inhibitor-17	Inhibitor	/	Unkown
HY-116191	WJD008	Inhibitor	/	Unkown
HY-N10133	Licoflavanone	Inhibitor	/	Unkown
HY-W781875	Sirolimus isomer C		/	Unkown
HY-W419331	Methionyl-methionine	Activator	/	Unkown
HY-19896A	COTI-2 hydrochloride	Inhibitor	/	Unkown
HY-N0836A	Jervine hydriodide	Inhibitor	/	Unkown
HY-N1677R	2,6-Dimethoxy-1,4-benzoquinone (Standard)		/	Unkown
HY-N10754	Aschantin	Inhibitor	/	Unkown
HY-164385	NSC126405	Inhibitor	99.20%	Unkown
HY-185457	BrAC-GGFG-Aminal-PI3K/mTOR-IN-21	Inhibitor	/	Unkown
HY-W780189	(rac)-Monepantel	Inhibitor	99.87%	Unkown
HY-Y1177R	Diphenyl disulfide (Standard)	Inhibitor	/	Unkown
HY-162023	mTOR inhibitor-10	Inhibitor	/	Unkown
HY-W074912	(S)-2-Amino-5,5,5-trifluoropentanoic acid	Inhibitor	/	Unkown
HY-110038	FTI-277 TFA	Inhibitor	/	Unkown
HY-155211	mTOR inhibitor-13	Inhibitor	/	Unkown
HY-W019868	1-O-Hexadecyl-2-O-acetyl-sn-glycerol	Inhibitor	/	Unkown
HY-164384	DFX117	Inhibitor	/	Unkown
HY-Y0252S8	L-Proline-d4	Activator	/	Unkown
HY-164662	mTOR inhibitor-24	Inhibitor	/	Unkown
HY-156484	SPR519	Inhibitor	/	Unkown
HY-180936	FBPase-IN-6	Modulator	/	Unkown
HY-N6926	1,3,5-Tricaffeoylquinic acid	Inhibitor	/	Unkown
HY-117923	PF-06465603	Inhibitor	/	Unkown
HY-N0143R	Phlorizin (Standard)	Inhibitor	/	Unkown
HY-N0819R	Raddeanin A (Standard)		/	Unkown
HY-N12531	Molephantin	Inhibitor	/	Unkown
HY-10218S1	Everolimus-13C2,d4	Inhibitor	/	Unkown
HY-134922	NS1-IN-1	Inhibitor	/	Unkown
HY-171229	1-Acetyl-DHAP	Substrate	/	Unkown
HY-162024	mTOR inhibitor-16	Inhibitor	/	Unkown
HY-155475	mTORC1-IN-2	Inhibitor	/	Unkown
HY-N10379	19-epi-Scholaricine	Inhibitor	99.14%	Unkown
HY-112903A	YW3-56 hydrochloride	Inhibitor	/	Unkown
HY-B0627S1	Metformin-13C2 hydrochloride		/	Unkown

Inhibitory Antibodies (3)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P992201	Anti-CD160 Antibody (MAT 302)	Activator	/	Unkown
HY-P990248	Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1)	Inhibitor	/	Unkown
HY-P992392	JM1-24-3	Inhibitor	/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Canis familiaris	MTOR	VGNC	VGNC:43490
Rattus norvegicus	MTOR	RGD	RGD:68371
Bos taurus	MTOR	VGNC	VGNC:31748
Macaca mulatta	MTOR	VGNC	VGNC:75062
Felis catus	MTOR	VGNC	VGNC:63657
Mus musculus	MTOR	MGD	MGI:1928394
Others	MTOR	NCBI